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Chromatin compartment dynamics in a
haploinsufficient model of cardiac laminopathy
Alessandro Bertero1,2,3, Paul A. Fields1,2,3, Alec S.T. Smith2,3,4, Andrea Leonard2,3,5, Kevin Beussman2,3,5, Nathan J. Sniadecki2,3,4,5,
Deok-Ho Kim2,3,4, Hung-Fat Tse6, Lil Pabon1,2,3, Jay Shendure7,8, William S. Noble7, and Charles E. Murry1,2,3,4,9
Mutations in A-type nuclear lamins cause dilated cardiomyopathy, which is postulated to result from dysregulated gene
expression due to changes in chromatin organization into active and inactive compartments. To test this, we performed
genome-wide chromosome conformation analyses in human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-
CMs) with a haploinsufficient mutation for lamin A/C. Compared with gene-corrected cells, mutant hiPSC-CMs have marked
electrophysiological and contractile alterations, with modest gene expression changes. While large-scale changes in
chromosomal topology are evident, differences in chromatin compartmentalization are limited to a few hotspots that escape
segregation to the nuclear lamina and inactivation during cardiogenesis. These regions exhibit up-regulation of multiple
noncardiac genes including CACNA1A, encoding for neuronal P/Q-type calcium channels. Pharmacological inhibition of the
resulting current partially mitigates the electrical alterations. However, chromatin compartment changes do not explain
most gene expression alterations in mutant hiPSC-CMs. Thus, global errors in chromosomal compartmentation are not the
primary pathogenic mechanism in heart failure due to lamin A/C haploinsufficiency.
Introduction
Chromatin organization in the 3D space has emerged as a key
layer of mammalian gene expression control. The development
of powerful technologies to map chromatin architecture, in
particular genome-wide chromosome conformation capture (Hi-
C; Lieberman-Aiden et al., 2009), has revealed that such 3D
structure is complex, nonrandom, and hierarchical (Yu and Ren,
2017). Short- and long-range intra-chromosomal (cis) DNA in-
teractions are generally constrained within topologically asso-
ciating domains (TADs; Dixon et al., 2012; Nora et al., 2012;
Sexton et al., 2012). TADs tend to interact based on their epi-
genetic status and transcriptional activity, thus dividing chro-
mosomes into two types of large-scale compartments generally
called active and inactive (A and B, respectively; Simonis et al.,
2006; Lieberman-Aiden et al., 2009; Rao et al., 2014).
Moving beyond the third dimension, there has been growing
interest in understanding the functional changes in chromatin
organization during development and in disease (Dekker et al.,
2017). An emerging body of work has shown that TADs are
largely invariant across cell types (Dixon et al., 2012, 2015;
Fraser et al., 2015; Schmitt et al., 2016; Won et al., 2016; Bertero
et al., 2019). However, these same studies have established that
pluripotent stem cell differentiation leads to a substantial degree
of A/B compartment reorganization (e.g., ∼20% of the genome),
and that this is associated with important developmental
changes in gene expression. In the context of disease, disruption
of TADs due to copy number variations or point mutations leads
to congenital developmental disorders and cancers (Katainen
et al., 2015; Lupiáñez et al., 2015; Redin et al., 2017; Sun et al.,
2018). In contrast, whether dysregulation of A/B compartments
plays a role in functional changes of gene expression leading to
human disease is still unclear (Krumm and Duan, 2018).
The nuclear lamina has been proposed as a regulator of
chromatin compartmentalization in development and disease
(Buchwalter et al., 2019). The lamina lies along the inner nuclear
membrane and is a complex mesh of nuclear intermediate fila-
ments (A- and B-type lamins) and lamin-associated proteins.
This structure provides key mechanical support to the nucleus,
and is an important hub for the control of intracellular signaling
.............................................................................................................................................................................
1Department of Pathology, University of Washington, Seattle, WA; 2Center for Cardiovascular Biology, University of Washington, Seattle, WA; 3Institute for Stem Cell and
Regenerative Medicine, University of Washington, Seattle, WA; 4Department of Bioengineering, University of Washington, Seattle, WA; 5Department of Mechanical
Engineering, University of Washington, Seattle, WA; 6Cardiology Division, Department of Medicine, University of Hong Kong, Pok Fu Lam, Hong Kong; 7Department of
Genome Sciences, University of Washington, Seattle, WA; 8Howard Hughes Medical Institute, Seattle, WA; 9Department of Medicine/Cardiology, University of
Washington, Seattle, WA.
Correspondence to Charles E. Murry: murry@uw.edu.
© 2019 Bertero et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the
publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0
International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
Rockefeller University Press https://doi.org/10.1083/jcb.201902117 1
J. Cell Biol. 2019
on August 8, 2019jcb.rupress.org Downloaded from 
http://doi.org/10.1083/jcb.201902117Published Online: 8 August, 2019 | Supp Info: 
(Dobrzynska et al., 2016). Moreover, the nuclear lamina inter-
acts with large chromatin regions, aptly named lamin-associated
domains (LADs; van Steensel and Belmont, 2017), which show
heterochromatic features such as low gene density, enrichment
for repressive histone marks, and poor transcriptional activity
(Guelen et al., 2008). Several studies have established that such
peripherally located LADs strongly correlate with the B com-
partment, while the A compartment is predominantly in the
nuclear interior (Kind et al., 2015; Luperchio et al., 2017; Stevens
et al., 2017; Zheng et al., 2018). Both lamins and lamin-associated
proteins, such as lamin B receptor, can directly interact with
chromatin (Yuan et al., 1991; Ye and Worman, 1994, 1996;
Taniura et al., 1995). Based on this and on the results of loss-of-
function studies, it has been proposed that the nuclear lamina
tethers LADs at the nuclear periphery (Solovei et al., 2013; Harr
et al., 2015; Luperchio et al., 2017). However, the precise role of
A- and B-type lamins in chromatin compartmentalization is still
being debated (Amendola and van Steensel, 2015; Zheng et al.,
2015, 2018; Adriaens et al., 2018).
Elucidating the function of A-type lamins (lamin A and lamin
C, which result from alternative splicing of the LMNA gene) is
particularly important because of their involvement in human
disease. LMNA mutations lead to a wide spectrum of conditions
collectively referred to as laminopathies, whichmost often affect
striated muscles (Capell and Collins, 2006; Bertrand et al., 2011).
The majority of patients with striated muscle laminopathies
develop dilated cardiomyopathy (DCM; Captur et al., 2018), and
mutations in LMNA are among the most common causes of fa-
milial DCM, depending on the ethnicity of the population
(Akinrinade et al., 2015; Haas et al., 2015; Tobita et al., 2018).
Compared with other types of DCM, LMNA-DCM (which
throughout the rest of the article we refer to as “cardiac lam-
inopathy”) is quite atypical and more severe, as it is character-
ized by early onset of life-threatening cardiac electrical
abnormalities such as severe conduction system disease and/or
atrial and ventricular arrhythmias (van Rijsingen et al., 2012;
Kumar et al., 2016; Hasselberg et al., 2018).
Over the nearly 20 yr since the first report linking mutations
in LMNA to human disease (Bonne et al., 1999), three central
nonmutually exclusive mechanisms have been hypothesized to
underpin the pathogenesis of cardiac laminopathy: (1) impaired
nuclear mechanoresistance via the nucleo–cytoplasmic net-
work, or “mechanical hypothesis”; (2) alteration of lamin A/C–
controlled intracellular signaling pathways, or “signaling
hypothesis”; and (3) dysregulation of heterochromatin organi-
zation leading to gene expression alterations, or “chromatin
hypothesis” (Worman and Courvalin, 2004; Cattin et al., 2013).
While evidence supporting the first two hypotheses has accu-
mulated over the years, and therapies targeting intracellular
signaling alterations are being preclinically developed (Cattin
et al., 2013; Captur et al., 2018), the possible involvement of
chromatin dysregulation in cardiac laminopathy is still far from
established (Adriaens et al., 2018). Indeed, while there have
been reports of changes in the nuclear positioning of selected
loci in patients with cardiac laminopathy (Meaburn et al., 2007;
Mewborn et al., 2010), the functional consequences of such
alterations on the disease pathogenesis are unclear. Moreover,
these studies have relied on fibroblasts instead of car-
diomyocytes, the primary cell type involved in cardiac lamin-
opathy. Most importantly, to the best of our knowledge, the 3D
chromatin organization changes associated with cardiac lam-
inopathy have not yet been tested at a genome-wide level.
To address these limitations, we performed Hi-C and gene
expression (RNA sequencing [RNA-seq]) analyses to examine
the changes in 3D chromatin architecture induced by a hap-
loinsufficient LMNA mutation in cardiomyocytes derived from
human induced pluripotent stem cells (hiPSC-CMs). We hy-
pothesized that decreased expression of A-type lamins would
lead to broad functional alterations in A/B compartmentaliza-
tion, leading to aberrant gene expression. However, our findings
indicate that while lamin A/C haploinsufficiency functionally
affects selected aspects of 3D chromatin organization in human
cardiomyocytes, altered A/B compartmentalization does not
represent the primary mechanism directly leading to gene ex-
pression changes and disease pathogenesis.
Results
Generation of an in vitro model of cardiac lamin
A/C haploinsufficiency
To investigate the role of chromatin dynamics in cardiac lam-
inopathy, we took advantage of hiPSCs bearing a heterozygous
nonsense mutation in LMNA predicted to cause premature
truncation of both lamin A and lamin C splicing isoforms
(c.672C>T, resulting in p.Arg225*, which we will refer to as
R225X; Fig. 1 A). This hiPSC line was previously derived from a
56-yr-old male patient who developed severe cardiac conduction
disease evolving into heart failure, a condition that segregated
within the family with autosomal-dominant inheritance of the
R225X mutation (Siu et al., 2012). This same mutation has been
reported in multiple other cohorts with similar symptoms
(Jakobs et al., 2001; van Tintelen et al., 2007a; Saga et al.,
2009), establishing it as a bona fide genetic cause of cardiac
laminopathy.
Since variability among hiPSC lines can profoundly influence
both molecular and cellular phenotypes, we generated isogenic
control hiPSCs by correcting the R225X mutation back to the
wild-type allele, a strategy currently considered the gold stan-
dard to determine the association between genotype and phe-
notype in hiPSC-CMs (Bellin et al., 2013; Kodo et al., 2016;
Mosqueira et al., 2018). By leveraging existing methods (Yusa,
2013), we designed a two-step scarless gene editing strategy
relying on CRISPR/Cas9-facilitated homologous recombination
of a targeting vector containing the wild-type allele in the 39
homology arm, and an excisable piggyBac drug resistance cas-
sette (Fig. S1, A and B). To control for the potential variability
between hiPSC sublines and for potential off-target mutations,
we obtained two isogenic control hiPSCs using distinct single
guide RNA (sgRNA) sequences (Fig. 1 B; and Fig. S1, C and D). The
resulting hiPSCs, which we subjected to extensive genomic
quality control (Fig. S1, E–G; and Table S1), will be referred to as
Corrected 1 and Corrected 2 (Corr.1 and Corr.2, respectively).
We differentiated hiPSCs into hiPSC-CMs using an estab-
lished protocol based on the temporal modulation of WNT
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signaling using small molecules (Burridge et al., 2014; Bertero
et al., 2019; Fig. 1 C). Both mutant and corrected hiPSCs could be
differentiated with high efficiency, as measured by flow cy-
tometry for TNNT2 (Fig. 1 D, Video 1, and Video 2; 91.6% ± 3.2%,
94.4% ± 2.5%, and 91.3% ± 3.1% for Mutant, Corr.1, and Corr.2,
respectively; average ± SEM of n = 4 independent differ-
entiations). Western blot, quantitative RT-PCR (RT-qPCR), flow
cytometry, and immunofluorescence analyses confirmed that all
hiPSC lines underwent the expected developmental progression
through mesoderm and cardiac progenitors before reaching a
cardiomyocyte phenotype (Fig. 1 F and Fig. S2, A–F). hiPSC-CMs
coexpressed NKX2-5 and TNNT2 (Fig. 1 D), excluding sinoatrial
node fate (Birket et al., 2015; Protze et al., 2017). Furthermore,
hiPSC-CMs from all lines showed comparable expression of the
mature ventricular marker cardiac troponin I (Fig. S2, G and H).
Interestingly, mutant hiPSC-CMs presented well-organized
sarcomeres and did not show any obvious sign of nuclear
blebbing or invagination, indicating that such abnormal
phenotypes often observed in patients may develop only after
long-term stress in vivo (Fig. S2, F and H; also see Fig. S3 D
described below). Collectively, the R225X lamin A/C mutation
does not substantially delay or otherwise impair cardiac dif-
ferentiation from hiPSCs.
Lamin A/C was up-regulated specifically in hiPSC-CMs, and
mutant lines showed significantly reduced levels of both mRNA
and protein compared with both corrected controls (Fig. 1, E–G).
Of note, no detectable protein truncation was detected by
Western blot (Fig. S3 A), and lamin A/C expression in mutant
hiPSC-CMs also proved to be reduced when compared with
cardiomyocytes generated from an unrelated hiPSC line derived
from a healthy individual (Fig. S3 B). Finally, other minor LMNA
isoforms were nearly undetectable by RT-qPCR in both control
and mutant hiPSC-CMs, excluding possible compensatory
mechanisms (Fig. S3 C). These gene expression data agree with
earlier findings from analysis of skin fibroblasts bearing the
R225X heterozygousmutation (Siu et al., 2012), and indicate that
Figure 1. Generation of lamin A/C hap-
loinsufficient hiPSC-CMs. (A) Predicted effect
of the LMNA R225X mutation on the two splicing
products lamin A and C. (B) Sanger sequencing
of LMNA exon 4 in hiPSCs with heterozygous
R225X mutation (top), or in hiPSCs obtained af-
ter CRISPR/Cas9-based scarless correction of
the mutation (bottom). (C) Schematic of the
protocol for step-wise directed differentiation of
hiPSC-CMs. CHIR, CHIR-99021; AA, ascorbic
acid. (D) Quantification of cardiac differentiation
efficiency by flow cytometry for TNNT2 and
NKX2-5 on hiPSC-CMs at day 14 of differentia-
tion. (E) RT-qPCR analyses at the indicated
stages of hiPSC-CM differentiation (see panel C).
Differences versus mutant were calculated by
two-way ANOVA with post hoc Holm–Sidak bi-
nary comparisons (*, P < 0.05; ***, P < 0.001; n= 3
differentiations; average ± SEM). (F) Representa-
tive Western blot for A- and B-type lamins and
differentiation markers during iPSC-CM dif-
ferentiation. (G) Quantification of lamin A/C
expression in hiPSC-CMs from Western blot
densitometries. Differences versus mutant
were calculated by one-way ANOVA with
post hoc Holm–Sidak binary comparisons
(**, P < 0.01; ***, P < 0.001; n = 3 differ-
entiations; average ± SEM). Throughout the
figure (and in all other figures), Mut or Mu-
tant indicates LMNA R225X hiPSCs, and
Corr.1/2 or Corrected 1/2 indicates the two
isogenic corrected control LMNA R225R
hiPSC lines.
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such premature nonsense mutation leads to lamin A/C hap-
loinsufficiency, presumably due to nonsense-mediated decay of
both the lamin A and lamin C transcripts. On the other hand,
B-type lamins were expressed at comparable levels and localized
normally in mutant and corrected hiPSC-CMs (Fig. 1 F and Fig.
S3, D and E), excluding compensatory mechanisms due to the
reduction of A-type lamins. Collectively, we established a robust
in vitro model to study cardiac laminopathy due to lamin A/C
haploinsufficiency in developing cardiomyocytes.
Lamin A/C haploinsufficiency alters hiPSC-CM automaticity
and prolongs membrane depolarization
Before exploring the effect of lamin A/C haploinsufficiency on
chromatin dynamics, we wished to confirm a phenotypic effect
on cardiac physiology in developing hiPSC-CMs. Since elec-
trical abnormalities are the primary and most characteristic
manifestations of cardiac laminopathy (van Rijsingen et al.,
2012; Kumar et al., 2016; Hasselberg et al., 2018), we began
by assessing the electrophysiological properties of mutant
hiPSC-CMs. For this, we first used multi-electrode arrays
(MEAs) to measure the extracellular electric field potential
elicited by spontaneously contracting monolayers of hiPSC-
CMs. Mutant cells showed a number of alterations compared
with both corrected controls. Most notably, the beat rate
proved highly erratic and prone to prolonged pauses (Fig. 2 A).
Moreover, even when the analysis was focused on the periods
showing the highest consistency, the beat rate was still more
irregular and reduced (Fig. 2 B). The amplitude of field po-
tential changes was elevated more than twofold compared with
controls, which is indicative of stronger depolarizing ion cur-
rents (Fig. 2 B). Along the same lines, the field potential dura-
tion (FPD), which indicates the interval between depolarization
and repolarization, was prolonged by ∼60% (Fig. 2 B). This
finding held true even when the FPD was corrected for the beat
period (FPDc; Fig. 2 B), an established way to robustly compare
the FPD across multiple conditions (Asakura et al., 2015; Rast
et al., 2016). Of note, despite all of these alterations, the con-
duction velocity across the monolayer was not affected (Fig. 2
B), indicating that intercellullar electrical coupling was pre-
served in mutant cells.
We also performed whole-cell patch clamp recordings of
voltage changes occurring during action potentials firing in in-
dividual cardiomyocytes. While a number of parameters were
unaffected inmutant cells (such as maximum diastolic potential,
action potential amplitude, mean diastolic potential, and repo-
larization amplitude; Fig. 2 D and data not shown), the action
potential duration and exponential time constant for the action
potential decay were increased (Fig. 2, C and D). This observa-
tion provided a cell-autonomous explanation for the increased
FPDc in cell monolayers.
Finally, we measured the effects of excitation abnormalities
inmutant cells on their intracellular calcium dynamics using the
fluorescent calcium reporter Fluo-4. Electrically paced mutant
cell monolayers showed stronger and longer calcium peaks
(Fig. 2, E and F; Video 3; and Video 4), in agreement with MEA
and patch clamp data. Overall, these findings indicate that lamin
A/C haploinsufficiency in developing cardiomyocytes leads to
altered automaticity and prolonged membrane depolarization,
leading to more robust calcium transients.
Systolic hyperfunction and diastolic dysfunction in lamin A/C
haploinsufficient hiPSC-CMs
Since changes in intracellular calcium concentrations are the
primary determinant of hiPSC-CM contractility, we examined
the effect of lamin A/C haploinsufficiency on this process. First,
we measured the cellular displacement associated with cardiac
contraction in electrically paced hiPSC-CM monolayers. Mutant
cells showed ∼50% stronger contractions and a delayed relaxa-
tion time (Fig. 3, A and B; Video 5; and Video 6), consistent with
their stronger and prolonged calcium fluxes.
To validate these findings in a more physiologically relevant
model, we performed biomechanical assessments of contractility
in electrically paced 3D engineered heart tissues (3D-EHTs), an
established model to promote cardiac maturation by providing
topological, mechanical, and multicellular cues (Ruan et al.,
2016; Leonard et al., 2018). In agreement with observations in
2Dmonolayers, mutant 3D-EHTs showed approximately twofold
stronger and prolonged contractions with a markedly impaired
relaxation kinetic (Fig. 3, C and D; Video 7; and Video 8). Col-
lectively, we concluded that lamin A/C haploinsufficiency leads
to systolic hyperfunction and diastolic dysfunction in both early
and maturing cardiomyocytes.
Lamin A/C haploinsufficiency causes dysregulation of specific
ion channel genes and moderate gene expression changes
To explore the molecular mechanisms that might explain the
electrophysiological and contractile phenotypes observed in
lamin A/C haploinsufficient hiPSC-CMs, we first monitored the
expression of the genes encoding key ion-handling proteins
involved in the generation of action potentials and in
excitation–contraction coupling (Amin et al., 2010; Eisner et al.,
2017). RT-qPCR analyses excluded a dysregulation of most such
genes (Fig. S3 F). However, mutant cells showed a significant
up-regulation of CACNA1C and down-regulation of KCNQ1 (Fig. 4
A). CACNA1C encodes for the pore-forming subunit of L-type
calcium channels, which mediate ICa,L, the main source of in-
ward depolarizing current during phase 2 (plateau) of the action
potential (Bodi et al., 2005). On the other hand, IKS, the outward
potassium current resulting from the potassium channel en-
coded by KCNQ1, antagonizes ICa,L in phase 2 by initiating
membrane repolarization (Peroz et al., 2008). Thus, the
combined effects of CACNA1C up-regulation and KCNQ1 down-
regulation could explain the prolonged membrane depolariza-
tion observed in mutant cells.
We then expanded these gene expression analyses genome-
wide by performing RNA-seq (Table S2). While hiPSC-CMs from
the two corrected control lines clustered closely and showed
remarkably similar gene expression profiles (Fig. 4 B and Table
S2), mutant cells clustered separately due to substantial gene up-
and down-regulation (Fig. 4, B and C; and Table S2). To increase
the robustness of our subsequent analyses, we only considered
genes as dysregulated if they had significant expression changes
in mutant hiPSC-CMs versus both corrected controls (185 up-
regulated and 140 down-regulated with fold-change >2 and q
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value <0.05; Fig. 4 C and Table S2). Ontology and pathway en-
richment analyses on these gene lists revealed that up-
regulation in mutant cells was significantly associated with (1)
focal adhesion, MAPK, and TGFβ pathways; (2) transcriptional
activation, positive regulation of cardiac differentiation, and
inhibition of apoptosis; and (3) noncardiac lineage expression
(such as genes preferentially expressed in fibroblast and smooth
muscle; Fig. 4 D and Table S3). In contrast, down-regulated
genes were enriched in cardiac transcripts and factors in-
volved in cardiomyopathy and phosphoinositide 3-kinase path-
ways (Fig. 4 D and Table S3). We also compared these RNA-seq
data with those we recently obtained from human embryonic
stem cells (hESCs) profiled at different time points of cardiac
differentiation (Bertero et al., 2019). Linear dimensionality re-
duction by principal component analysis showed that both
mutant and corrected hiPSC-CMs clustered closely to hESC-
derived cardiomyocytes (hESC-CMs; Fig. 4 E). This indicated
that despite dysregulation of >300 genes and of multiple sig-
naling pathways, mutant hiPSC-CMs were not globally devel-
opmentally delayed from a transcriptional standpoint.
Lamin A/C haploinsufficiency strengthens the separation
between chromosome territories and between
chromatin compartments
Having established that lamin A/C haploinsufficiency results in
clear changes in both cellular physiology and gene expression in
developing hiPSC-CMs, we tested whether some of these phe-
notypes could be explained by changes in chromatin topology.
To explore this aspect at a genome-wide level, we took advan-
tage of in situ DNase Hi-C to capture all pairwise interactions
between any two genomic regions (Ramani et al., 2016). Hi-C
data frommutant and corrected hiPSC-CMs were of high quality
Figure 2. Electrophysiological properties of lamin A/C haploinsufficient hiPSC-CMs. (A) Representative traces from MEA recordings of spontaneous
electrical activity in hiPSC-CMmonolayers. (B) Representative quantifications of electrophysiological properties fromMEA analyses. Differences versus mutant
were calculated by one-way ANOVA with post hoc Holm–Sidak binary comparisons (**, P < 0.01; ***, P < 0.001; n = 5–16 wells; average ± SEM).
(C) Representative voltage recordings by whole-cell patch clamp during evoked action potentials in individual hiPSC-CMs. (D) Quantifications of electro-
physiological properties from whole-cell patch clamp analyses (APD90, action potential duration at 90% repolarization). Differences versus mutant were
calculated by one-way ANOVA with post hoc Holm–Sidak binary comparisons (*, P < 0.05; **, P < 0.01; ***, P < 0.001; n = 26–30 cells from two differ-
entiations; average ± SEM). (E) Representative optical recordings of calcium fluxes with Fluo-4 in hiPSC-CMmonolayers electrically paced at 1 Hz (Fmax, peak
fluorescence; F0, baseline fluorescence). (F) Representative quantifications of calcium fluxes properties. Differences versus mutant were calculated by un-
paired t test (***, P < 0.001; n = 69–70 cells; average ± SEM).
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and reproducible across biological replicates, with samples
clustering separately based on their genotype (Fig. 5 A and Table
S4). We then began exploring the global properties of chromatin
topology and noticed that mutant cells showed an increased ratio
of genomic interactions within the same chromosome (in cis)
over those involving different chromosomes (in trans; Fig. 5 B).
Moreover, trans interactions were distributed differently: while
all hiPSC-CMs showed the expected pattern of preferential self-
association between small, gene-rich chromosomes (especially
chromosomes 16, 17, 19, 20, and 22) and between large, gene-
poor chromosomes (such as chromosomes 1–8; Fig. S4 A;
Lieberman-Aiden et al., 2009), this property was even more
striking in mutant cells (Fig. 5 C). On the contrary, interactions
between small and large chromosomes were less frequent (Fig. 5
C). Thus, lamin A/C haploinsufficiency reinforces the separation
between chromosome territories and their segregation based on
size and gene density.
We then analyzed the separation of chromatin domains into
the A or B compartment. For this, we computed the first prin-
cipal component (PC1) from the contact matrix using bins of 500
kb (Table S5), a well-established method to determine chroma-
tin compartments based on their preferential association
(Lieberman-Aiden et al., 2009; Imakaev et al., 2012). In agree-
ment with our previous observations in hESC-CMs (Bertero
et al., 2019), trans interactions between chromatin domains fa-
vored A-A compartments, and this was not affected by lamin
A/C haploinsufficiency (Fig. S4 B). In cis, mutant cells showed
stronger interactions between A-A compartments (Fig. 5 D and
Fig. S4 B), particularly due to increased short-range contacts
within 0.5–1 Mb (Fig. 5 E). In contrast, interactions between
heterotypic regions (A-B) were reduced in mutant cells
(Fig. 5 D and Fig. S4 B), particularly for long-range contacts
>10 Mb (Fig. 5 E). Collectively, lamin A/C haploinsufficiency
reinforces the separation between the active and inactive
chromatin compartments.
Incomplete transitions from the active to inactive chromatin
compartment in lamin A/C haploinsufficient hiPSC-CMs
To further assess the effect of lamin A/C haploinsufficiency on
chromatin compartmentalization, we identified genomic bins
with significantly different A/B compartment scores and
switching from active to inactive or vice versa between at least
two conditions (Table S5). We noticed that the vast majority of
compartment transitions were observed for mutant hiPSC-CMs
versus each corrected control (Fig. 6 A), and that B to A in-
versions were more common than A to B ones (42 and 27, re-
spectively; Table S5). We observed that 63% of A to B transitions
in mutant cells involved the X chromosome, while B to A
changes showed a notable concentration on chromosome 19 but
were otherwise evenly spread across 13 additional chromosomes
(Fig. 6 B, Fig. S5 A, and Table S5). Overall, compartment changes
involved ∼1.2% of the genome, indicating that chromatin com-
partment dysregulation in mutant cells is not widespread but is
actually highly restricted.
To gain insight into the relationship between dysregulated
regions and normal chromatin compartment dynamics during
cardiomyocyte differentiation, we integrated Hi-C data from
mutant and corrected hiPSC-CMs with those we previously
generated at different time points throughout hESC-CM differ-
entiation (Bertero et al., 2019). Linear dimensionality reduction
of A/B compartment scores for all samples confirmed that mu-
tant hiPSC-CMs cluster separately from both corrected controls
(Fig. 6 C).Moreover, this analysis revealed that based on the first
principal component (which explained 39% of the variance and
ordered hESC samples based on their developmental progres-
sion), mutant cells were mildly developmentally delayed from a
Figure 3. Contractile properties of lamin A/C haploinsufficient hiPSC-CMs. (A) Representative measurements of cellular displacement during contraction
of hiPSC-CM monolayers electrically paced at 1 Hz. (B) Representative quantifications of cell contractility from analyses of optical recordings. Differences
versus mutant were calculated by one-way ANOVA with post hoc Holm–Sidak binary comparisons (*, P < 0.05; n = 5–6 FOVs; average ± SEM). (C) Repre-
sentative measurements of twitch force during contraction of 3D-EHTs electrically paced at 1 Hz. (D) Representative quantifications of tissue contractility from
analyses of optical recordings. Differences versus mutant were calculated by one-way ANOVA with post hoc Holm–Sidak binary comparisons (*, P < 0.05; **,
P < 0.01; ***, P < 0.001; n = 4–5 3D-EHTs; average ± SEM).
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chromatin compartmentalization standpoint (Fig. 6 C, PC1).
Accordingly, we observed a strong and significant enrichment
for domains that normally transition from A to B during cardiac
differentiation but remain in A inmutant cells (Fig. 6 D). Notable
examples of such behavior involved two 0.5- and 2.5-Mb-long
portions of chromosome 19 (corresponding to 19p13.13 and
19q13.33, respectively), and a 1-Mb region on chromosome 5
(5q31.3; Fig. 6, B and E). We also observed a weaker enrichment
for the opposite dynamic (impaired B to A transitions; Fig. 6 D),
but we note that this analysis was limited to autosomes since
compartment transitions of the X chromosome could not be
assessed in female hESC-CMs due to the confounding factor of X
inactivation.
We previously showed that transition from the B to A com-
partment during cardiogenesis often reflects relocalization of
loci from the nuclear periphery to the nuclear interior (Bertero
et al., 2019), in agreement with the notion that the B compart-
ment contains the vast majority of LADs (Luperchio et al., 2017).
Thus, we speculated that the opposite could also be true, and that
lack of transition from the A to B compartment inmutant hiPSC-
CMs might reflect impairment of translocation to peripheral
LADs. We tested this by combined immunofluorescence for the
Figure 4. Gene expression changes in lamin A/C haploinsufficient hiPSC-CMs. (A) RT-qPCR analyses in hiPSC-CMs at day 14 of differentiation. Differences
versus mutant were calculated by one-way ANOVA with post hoc Holm–Sidak binary comparisons (*, P < 0.05; n = 3 differentiations; average ± SEM). (B)
Hierarchical clustering of hiPSC-CMs analyzed by RNA-seq based on all expressed genes. r, replicate. (C) Overlap in genes up- or down-regulated in mutant
hiPSC-CMs versus hiPSC-CMs from the two corrected control lines (change greater than twofold and q-value <0.05; Table S2). (D) Selected results from gene
ontology (GO) and pathway enrichment analyses of genes consistently up- or down-regulation in mutant hiPSC-CMs. KEGG, Kyoto Encyclopedia of Genes and
Genomes. (E) Linear dimensionality reduction by principal component (PC) analysis of RNA-seq data of mutant and corrected hiPSC-CMs, and hESC-CMs
sampled at different time points of differentiation.
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nuclear lamina and 3D-DNA FISH for three loci contained within
genomic locations showing aberrant compartmentalization in
mutant hiPSC-CMs: CACNA1A, LRRC4B, and PCDHGB4 (Fig. 6 E).
Analysis of hiPSCs versus hiPSC-CMs showed that both CAC-
NA1A and LRRC4B moved closer to the nuclear lamina during
differentiation, but that this transition was less marked in mu-
tant hiPSC-CMs (Fig. 7, A and B). Interestingly, PCDHGB4 did not
change localization either during differentiation or in mutant
hiPSC-CMs (Fig. 7 B), indicating that aberrant compartmentali-
zation of this chromatin region does not result from changes in
association to the nuclear lamina, and thus it must reflect some
other mechanism. As controls, we selected VAV1 and LGALS14,
which transition from the A to B compartment both in mutant
and corrected hiPSC-CMs (Fig. 7 C) and are found on the same
chromosome arms as CACNA1A and LRRC4B, respectively. These
regions demonstrated the expected localization change during
differentiation both in mutant and corrected hiPSC-CMs (Fig. 7
B), establishing that the impairment observed for CACNA1A and
LRRC4B does not merely result from differentiation-associated
changes in the territory of chromosome 19. In sum, lamin A/C
haploinsufficiency in developing hiPSC-CMs results in highly
selective dysregulation of chromatin compartmentalization,
particularly for a handful of genomic hotspots that fail to tran-
sition from the active compartment in the nuclear interior to the
inactive compartment associated to the nuclear lamina. We will
refer to these as lamin A/C–sensitive B domains.
Dysregulation of lamin A/C–sensitive B domains leads to
ectopic expression of noncardiac genes
We then assessed the functional consequences of compart-
ment dysregulation due to lamin A/C haploinsufficiency.
Strikingly, we observed almost no overlap between genes
within lamin A/C–sensitive domains and genes significantly
and strongly up- or down-regulated in mutant cells (Fig. S5 B).
Accordingly, there were no significant changes in the average
expression of genes found in lamin A/C–sensitive domains in
mutant versus corrected controls (Fig. 8 A). Nevertheless, we
noticed a small number of genes located in lamin A/C–
sensitive B domains that were expressed at very low levels in
corrected hiPSC-CMs and up-regulated in mutant cells (29
genes with an average change greater than twofold; Fig. 8 A
and Fig. S5 C). These genes were significantly enriched for
three chromosome locations (Fig. 8 B), two of which corre-
sponded to the lamin A/C–sensitive hotspots 5q31.3 and
Figure 5. Global properties of chromatin topology in lamin A/C haploinsufficient hiPSC-CMs. (A)Hierarchical clustering of hiPSC-CMs analyzed by in situ
DNase Hi-C based on similarity scores between the genomic contact matrices calculated with HiCRep. (B) Proportion of trans or cis interactions involving
distances <20 kb (cis short) or >20 kb (cis long; Table S4). Differences versus mutant were calculated by two-way ANOVA with post hoc Holm–Sidak binary
comparisons (*, P < 0.05; n = 2 differentiations; average ± SEM). (C) Representative heatmaps of differential contact matrices between autosomes (ordered by
size). (D) Representative heatmaps of differential cis interactions between A and B compartments. (E) Probability of cis genomic contacts over increasing
genomic distance for regions in homotypic (A-A or B-B) or heterotypic (A-B) chromatin compartments (gray background: 95% confidence bands). obs/exp,
observed/expected.
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Figure 6. Chromatin compartment transitions in lamin A/C haploinsufficient hiPSC-CMs. (A) Heatmap of all significantly different A/B compartment
scores (Hi-C matrix PC1; P < 0.05 by one-way ANOVA; n = 2 differentiations; Table S5) in 500-kb bins that changed PC1 sign between two or more conditions.
Positive and negative PC1 indicate A and B compartmentalization, respectively. (B) Representative log-transformed contact probability maps for chromosome
19. TADs are visible as squares along the diagonal. TADs within the same compartment interact off the diagonal as indicated by the symmetrical checkerboard
patterns. Two genomic regions that show different compartmentalization in mutant hiPSC-CMs are indicated by dashed boxes to highlight the differences in
contact probabilities with other genomic regions off the diagonal. (C) Linear dimensionality reduction by principal component (PC) analysis of A/B com-
partment scores from Hi-C data of mutant and corrected hiPSC-CMs, and hESC-CMs sampled at different time points of differentiation. (D) Significance of the
overlap between changes in A/B compartments in mutant hiPSC-CMs and those occurring during hESC-CM differentiation. The number of genomic bins within
each of the categories is indicated, and P values were calculated by χ2 tests. (E) Representative genomic tracks of chromatin compartmentalization for
chromosome 19 and a section of chromosome 5. Positive and negative Hi-C matrix PC1 scores are shown in red and blue, and indicate 500-kb genomic bins in
the A and B compartments, respectively. Genomic regions that transition from A to B during hESC-CM differentiation but remain in A in mutant hiPSC-CMs
(noted as B to A) are indicated by dashed boxes. Selected genes found within such regions are listed (refer to Fig. 8 and Fig. S5).
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19q13.33 (Fig. 6 E), and were associated with neuronal devel-
opment (Fig. 8 B and Table S6).
Of note, most genes in the group just described had not been
determined as differentially expressed based on RNA-seq
analysis using Cufflinks, since lowly expressed genes are sub-
ject to strong negative penalization when calculating the q score
due to the challenges in robustly assessing their expression
(Trapnell et al., 2010, 2012). This explains their absence in the
lists used for the overlap shown in Fig. S5 B. To increase our
confidence with these results, we validated the expression of
several genes within this class by RT-qPCR. Moreover, to ex-
clude that such gene expression differences were simply ex-
plained by a differentiation delay in mutant hiPSC-CMs, we
analyzed their expression during cardiac differentiation as well
as in hiPSC-CMs matured either by longer 2D culture or by the
generation of 3D-EHTs. Remarkably, nearly all genes tested
were not expressed during normal cardiogenesis, and showed
strongest up-regulation in mutant hiPSC-CMs and 3D-EHTs
(Fig. 8, C and D; and Fig. S5, D–F). These findings confirmed
that impaired transition to the B compartment of selected lamin
A/C–sensitive domains leads to up-regulation of multiple non-
cardiac genes that would otherwise be transcriptionally re-
pressed during cardiomyocyte differentiation.
Ectopic P/Q-type and potentiated L-type calcium currents
contribute to electrophysiological abnormalities of lamin A/C
haploinsufficient hiPSC-CMs
Genes found in lamin A/C–sensitive B domains and up-regulated
in mutant hiPSC-CMs included multiple factors with either
unknown function, such as the putative uncharacterized protein
C19orf81, or with established roles in the nervous system but not
normally expressed in the heart (Fig. 8, C and D; and Fig. S5,
D–F). This group included genes from all of the three proto-
cadherin clusters on chromosome 5 (α, β, and γ, exemplified by
PCDHA10, PCDHB15, and PCHDGB4; Chen and Maniatis, 2013),
LRRC4B (encoding for the postsynaptic cell adhesion molecule
NGL-3; Maruo et al., 2017), SYT3 (involved in postsynaptic en-
docytosis; Awasthi et al., 2018), and CACNA1A (which encodes for
the pore-forming subunit of neuronal P/Q-type calcium chan-
nels; Rajakulendran et al., 2012).
CACNA1A appeared particularly interesting given the pro-
longed action potential duration observed in mutant hiPSC-CM
populations. Indeed, the depolarizing ICa,P and ICa,Q currents
resulting from the protein product of CACNA1A are known to be
strong and long-lasting, even more so than ICa,L currents typical
of hiPSC-CMs (Catterall et al., 2005; Nimmrich and Gross, 2012).
Thus, we tested whether ICa,P and ICa,Q currents contributed to
Figure 7. Alterations in peripheral localization of lamin A/C–sensitive loci. (A) Representative immunoFISH for the nuclear lamina (lamin B1), the cardiac
marker α-actinin, and the CACNA1C locus in mutant and corrected hiPSCs and hiPSC-CM (nuclei counterstained with DAPI). Scale bars, 5 µm. (B)Quantification
of the distance between the indicated loci and the nuclear lamina in diploid cells based on immunoFISH data. Violin plots report the whole range, and horizontal
lines indicate the first quartile, median, and third quartile. Statistical analysis by Brown–Forsythe and Welch ANOVA test followed by the Holm–Sidak multiple
comparisons versus hiPSC for the same line or versus mutant, as indicated (*, P < 0.05; **, P < 0.01; ***, P < 0.001; n = individual loci, as indicated). (C) As in
Fig. 6 E, but reporting chromatin compartmentalization changes for two genomic regions not affected by lamin A/C haploinsufficiency and used as negative
control for immunoFISH experiments (B).
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the electrophysiological abnormalities of mutant cells by in-
hibiting such currents using two structurally unrelated, highly
specific inhibitors derived from spider venoms: ω-conotoxin
MVIIC and ω-agatoxin TK (Adams et al., 1993; McDonough
et al., 1996; Nimmrich and Gross, 2012). MEA experiments
demonstrated that both toxins led to a modest but significant
decrease in the FPDc in monolayers of mutant hiPSC-CMs, while
they did not affect their depolarization amplitude (Fig. 9, A and
B). In contrast, neither toxin had a significant effect on the FPDc
in corrected controls (Fig. 9, A and B), confirming that ICa,P and
ICa,Q currents do not play a role in cardiac depolarization in
physiological conditions, and establishing that the toxins had no
overt nonspecific effects on hiPSC-CM electrophysiology at the
doses tested. These experiments indicated that ectopic expres-
sion of CACNA1A in mutant cells and the resulting P/Q-type
calcium currents contribute to the prolonged depolarization
observed in lamin A/C haploinsufficient hiPSC-CMs.
Asmentioned above, we also observed CACNA1C up-regulation
and KCNQ1 down-regulation in mutant hiPSC-CMs at day 14 of
differentiation (Fig. 4 A). RT-qPCR analyses in hiPSC-CMs
matured for a longer period in 2D monolayers or in 3D-EHTs
indicated that KCNQ1 down-regulation was specific to early
hiPSC-CMs (Fig. 9, C and D). On the other hand, up-regulation of
CACNA1C was maintained in more mature hiPSC-CMs (Fig. 9, C
and D). Of note, CACNA1C is a gene always found in the A chro-
matin compartment throughout hiPSC-CM differentiation
(Bertero et al., 2019), and such localization was unaltered in
mutant hiPSC-CMs (Table S5). Given the established role of ICa,L
in the development and maintenance of the cardiac action po-
tential (Catterall et al., 2005), we tested if its inhibition with the
L-type calcium blocker verapamil could revert the electrophysi-
ological abnormalities of mutant hiPSC-CMs. Remarkably, low
concentrations of verapamilmarkedly reduced both the FPDc and
the spike amplitude of mutant hiPSC-CMmonolayers, while they
had little or no effect on corrected controls (Fig. 9 E). Overall, we
conclude that the combination of ectopic P/Q-type calcium cur-
rents due to aberrant chromatin compartment dynamics, and of
enhanced L-type calcium currents via other epigenetic mecha-
nisms, lead to the electrophysiological abnormalities of laminA/C
haploinsufficient hiPSC-CMs (Fig. 10).
Figure 8. Correlation between altered chromatin compartmentalization and gene expression changes in lamin A/C haploinsufficient hiPSC-CMs.
(A) Violin plots showing the expression of genes found with lamin A/C–sensitive domains. Boxplots indicate the first quartile, median, and third quartile, while
whiskers are from the 5th to 95th percentiles. In the left panel, note that the tail of genes expressed at very low levels in corrected hiPSC-CMs is less
pronounced in mutant cells. (B) Selected results from ontology enrichment analyses of up-regulated genes in domains aberrantly found in the A compartment
in mutant hiPSC-CMs (average fold-change greater than two; Fig. S5 C). (C and D) RT-qPCR validation of gene expression changes in hiPSC-CMs matured by
culture in vitro for 30 d (C) or by generation of 3D-EHTs (D). Differences versus mutant were calculated by one-way ANOVA with post hoc Holm–Sidak binary
comparisons (*, P < 0.05; **, P < 0.01; n = 4 differentiations for panel C, and n = 3 3D-EHT batches for panel D; average ± SEM). RPKM, read kilobase per million
mapped reads.
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Discussion
Disease modeling of cardiac laminopathy in
developing cardiomyocytes
Because the earliest manifestation of cardiac laminopathy is
severe electrical abnormalities in the myocardium (van
Rijsingen et al., 2012; Kumar et al., 2016; Hasselberg et al.,
2018), our observations of aberrant electrophysiological prop-
erties in mutant hiPSC-CMs may be noteworthy. While alter-
ations in cardiac rhythm could have been anticipated given the
clinical manifestations of this disease, we were surprised to note
increased FPDc and action potential duration. The FPD is the
in vitro analogue of the QT interval measured by electrocardi-
ogram (which indicates the interval between ventricular depo-
larization and repolarization). Genetic or acquired prolongation
of QT interval is a strong risk factor for development of severe
arrhythmias (Vandael et al., 2017), and QT interval prolongation
has been reported in patients with LMNA mutations causing
cardiac laminopathy (Pan et al., 2009), Emery–Dreifuss mus-
cular dystrophy (Russo et al., 2012), and Hutchinson–Gilford
progeria syndrome (Merideth et al., 2008). Although prolonged
QT has not been widely described as a hallmark of cardiac
laminopathy, we speculate that this could be an underappreci-
ated early clinical phenotype. Prolonged QT and subsequent
increase in calcium influx might predispose patients to cardiac
arrhythmias and/or could be an early marker of a broader
conduction system disease.
A striking phenotype of the laminopathic cardiomyocytes
was their enhanced contractility in monolayers and in EHTs.
Increased contractility can be explained by the prolonged action
potentials and stronger calcium fluxes that these myocytes ex-
hibit. At a first glance, greater contractility might appear to
conflict with the clinical phenotype of some laminopathy pa-
tients who develop systolic heart failure. However, in contrast to
the early onset and highly penetrant malignant conduction
disease, left ventricular dilatation and systolic failure are expe-
rienced by just a fraction of cardiac laminopathy patients and
only after years after the initial diagnosis (van Berlo et al., 2005;
Kumar et al., 2016; Tobita et al., 2018). Moreover, heart failure is
a complex disease that involves multiple cell types as well as
the extracellular matrix (Metra and Teerlink, 2017). Thus, we
Figure 9. Role of P/Q- and L-type calcium currents in electrophysiological abnormalities of lamin A/C haploinsufficient hiPSC-CMs. (A and B)
Representative quantifications of electrophysiological properties from MEA analyses in standard culture conditions or after treatment with the indicated
inhibitors for P/Q-type calcium channels (ω-conotoxin MVIIC: 2 µM; ω-agatoxin TK: 0.5 µM). Differences versus mutant were calculated by one-way ANOVA
with post hoc Holm–Sidak binary comparisons (*, P < 0.05; **, P < 0.01; n = 3–8 wells; average ± SEM). (C and D) RT-qPCR validation of gene expression
changes in hiPSC-CMs matured by culture in vitro for 30 d (C) or by generation of 3D-EHTs (D). Differences versus mutant were calculated by one-way ANOVA
with post hoc Holm–Sidak binary comparisons (*, P < 0.05; **, P < 0.01; ***, P < 0.001; n = 4 differentiations for panel C, and n = 3 3D-EHT batches for panel D;
average ± SEM). (E) As in panels A and B, but hiPSC-CMs were treated with increasing doses of the L-type calcium channel blocker verapamil (*, P < 0.05; ***,
P < 0.001; n = 1–4 wells; average ± SEM).
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propose that the systolic hyperfunction and diastolic dys-
function of lamin A/C haploinsufficient hiPSC-CMs might
reflect an early and cell-autonomous phenotype of cardiac
laminopathy, which over the years can evolve into an organ-
level disease characterized by decreased systolic function. A
possible mechanism for this could be the chronic calcium
overload in laminopathic cardiomyocytes, as this is a well-
established stimulus that can lead to DCM due to activation
of signaling pathways such as calcineurin/NFAT (Molkentin
et al., 1998; Nakamura et al., 2008; Zhang et al., 2016). Addi-
tionally, it was previously shown that laminopathic car-
diomyocytes are highly sensitive to apoptosis (Ho et al., 2011;
Lee et al., 2017), which could over the years contribute to the
development of severe cardiac fibrosis that is typical in car-
diac laminopathy patients (van Tintelen et al., 2007b; Fontana
et al., 2013; Tobita et al., 2018). A corollary of these intriguing
hypotheses is that medical interventions during the early
phases of the disease, such as the use of calcium antagonists
(such as our use of verapamil here) and/or anti-apoptotic
agents (Lee et al., 2014; Nie et al., 2018), may be able to pre-
vent the development of heart failure in cardiac laminopathy
patients.
Chromatin architecture changes in lamin A/C
haploinsufficient cardiomyocytes
The major hypothesis going into this study was that lamin A/C
haploinsufficiency would induce widespread gene dysregulation
due to inappropriate A/B compartmentalization, the so-called
“chromatin hypothesis” for the pathogenesis of cardiac lamin-
opathy (Worman and Courvalin, 2004; Cattin et al., 2013). This
hypothesis was not robustly supported. RNA-seq analysis
showed that only ∼325 genes were strongly up- or down-
regulated in laminopathic cardiomyocytes. Analysis of A/B
compartment changes revealed that only ∼1.2% of the genome
changed compartments in LMNAmutants, and these aberrations
were concentrated in hotspots on chromosomes 5 and 19. Sur-
prisingly, the overlap between strong dysregulation in gene
expression and compartment aberrations was minimal (<2%;
Fig. S5 B). As discussed below, the CACNA1A gene is ectopically
expressed and resides in an A compartment that fails to silence
during differentiation. Thus, while examples can be found that
may contribute to disease, most of the transcriptional dysregu-
lation appears to result from factors other than errors in com-
partmentalization. Overall, these findings do not support the
“chromatin hypothesis” for the pathogenesis of cardiac lamin-
opathy. On the other hand, our results agree with previous
findings frommouse embryonic stem cells, in which depletion of
B-type nuclear lamins results in minimal changes in A/B com-
partmentalization (Amendola and van Steensel, 2015; Zheng
et al., 2015, 2018). Our results establish that while A-type lam-
ins seem to participate in chromatin organization in developing
cardiomyocytes, lamin A/C haploinsufficiency leads to only
modest alterations in A/B compartmentalization even in me-
chanically active cells.
Interestingly, we identify CACNA1A as a disease-associated
gene linked to alterations of A/B compartmentalization. CAC-
NA1A is normally expressed throughout the nervous systemwith
the highest expression on Purkinje neurons in the cerebellum
and in cerebellar granular cells (Nimmrich and Gross, 2012). Its
ectopic expression and the modest contribution of the resulting
P/Q-type calcium currents on FPDc prolongation in lamin A/C
haploinsufficient hiPSC-CMs suggest that this may represent a
therapeutic target to ameliorate the electrical abnormalities in
the myocardium of cardiac laminopathy patients. Further as-
sessments of CACNA1A expression in patient-derived primary
samples will be of high interest.
If chromatin compartment alterations do not directly explain
the majority of gene expression changes observed in lamin A/C
haploinsufficient hiPSC-CMs, what is driving these changes? An
important example of this behavior is CACNA1C, which is up-
regulated in mutant cells while not changing compartmentali-
zation. At least two nonexclusive possibilities come to mind.
First, it remains possible that alterations in chromatin organi-
zation play a primary role, albeit not in the form of outright
changes in A/B compartmentalization. For instance, it was re-
ported that B-type lamins can indirectly affect the expression of
Figure 10. Proposed model for the chromatin compartmentalization–dependent and –independent effects of lamin A/C haploinsufficieny in de-
veloping hiPSC-CMs. Compartmentalization and pheripheral localization of few genomic hotspots is dysregulated (exemplified by the magenta and green loci),
while a large number of genes are dysregulated independently of chromatin compartment changes (exemplified by the red locus).
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genes within the nuclear interior by affecting the interaction
between TADs as a consequence of distal alterations in LAD
compaction (Zheng et al., 2018). It is thus possible that A-type
lamins might have a similar role, which will be interesting
to test in detail in future studies. A second possibility for
compartment-independent gene expression changes might be
the result of changes in intracellular signaling pathways such as
MAPK andmTOR. Indeed, such pathways have well-established
links with the nuclear lamina (Dobrzynska et al., 2016) and are
up-regulated in animal models of cardiac laminopathy (Muchir
et al., 2007, 2012; Choi et al., 2012).
Emerging evidence suggests that nonsense/haploinsufficency
mutations in LMNA may have a different pathogenesis than
missense mutations. We have recently collaborated to study a
heterozygous K219T missense mutation in LMNA (Salvarani
et al., 2019). Interestingly, this mutation leads to distinct elec-
trophysiological abnormalities, namely reduced peak sodium
current and diminished conduction velocity, which are caused
by down-regulation of SCN5A as result of closer proximity to
the nuclear lamina and increased H3K27me3. In the current
study, we have not observed a similar reduction of SCN5A ex-
pression in lamin A/C haploinsufficient hiPSC-CMs (Fig. S3 F).
Furthermore, our Hi-C data indicate that the SCN5A gene is
found in a chromatin domain, which is always part of the A
compartment both throughout normal cardiac differentiation
(Bertero et al., 2019) and in lamin A/C haploinsufficient hiPSC-
CMs (Table S5). These observations prompt the intriguing
hypothesis that haploinsufficient and missense mutations in
LMNAmight lead to cardiac laminopathy via distinct molecular
mechanisms.
In conclusion, our work establishes that while lamin A/C
haploinsufficient hiPSC-CMs show marked alterations in
electrophysiology, contractility, and chromosomal topology,
phenotypic changes cannot, for the most part, be directly
explained by alterations in chromatin compartmentalization.
With this in mind, it is important to mention that this study
does not come without limitations. We acknowledge that
modeling diseases of the adult heart in immature hiPSC-CMs
suffers from inherent drawbacks. It is possible that functional
chromatin dysregulation could be more important in adult
myocytes subjected to high levels of mechanical stress in vivo.
Addressing this aspect will require substantial advances in
our ability to mature hiPSC-CMs and/or improvements of
genome-wide chromatin conformation capture technologies
in order to reliably measure chromatin architecture from
small numbers of myocytes isolated from precious primary
samples. Furthermore, replication of our findings in addi-
tional hiPSC lines with nonsense/haploinsufficient mutations
will be important, as our study focused on only one such
mutant line. Finally, future studies will be required to test
whether other types of mutations (such as missense changes
like the aforementioned K219T mutation) result in more sub-
stantial genome-wide alterations in chromatin topology than
what was observed following lamin A/C haploinsufficiency. All
considered, our work provides a stepping stone toward un-
derstanding the relevance of the “chromatin hypothesis” in the
pathogenesis of cardiac laminopathy.
Materials and methods
hiPSC culture and differentiation
hiPSCs were cultured and differentiated into cardiomyocytes
(hiPSC-CMs) with minor modifications of previously described
methods (Burridge et al., 2014; Bertero et al., 2019). hiPSCs
were cultured on plates precoated with 0.5 µg/cm2 recombi-
nant human Laminin-521 matrix (diluted in PBS with Ca2+
and Mg2+; rhLaminin521; Biolamina) with daily changes of
antibiotic-free Essential 8 (E8) media (Thermo Fisher Scien-
tific). Cells were passaged as small clumps with Versene
(Thermo Fisher Scientific), and 10 µM Y-27632 (Tocris) was
added for the first 16 h.
For hiPSC-CM generation, cells were passaged as single cells
with Versene, and seeded at a density of 2.5 × 105 per well of a
12-well plate precoated with 2 µg/cm2 rhLaminin521 (denoted
day −2). After 24 h, medium was changed to E8 with 1 µM
CHIR-99021 (Cayman), denoted day −1. On day 0, medium was
changed to RBA media (RPMI-1640 with glutamine [Thermo
Fisher Scientific] supplemented with 500 µg/ml BSA and
213 µg/ml ascorbic acid [both from Sigma-Aldrich]) supple-
mented with 4 µM CHIR-99021. At day 2, medium was changed
to RBA with 2 µM WNT-C59 (Selleckchem). On day 4, medium
was changed to RBA. On day 6, medium was changed to RPMI-
B27 media (RPMI with 1× B-27 supplement; both from Thermo
Fisher Scientific), with further media changes every other day.
Beating was first observed between day 7 and day 9, and cells
were cultured until day 14 before collection (unless otherwise
indicated). hiPSC-CMs to be used for assays at later stages of
differentiation were preconditioned with a 30-min heat shock
at 42°C on day 13 and cryopreserved at day 14 following single-
cell dissociation using 0.25% wt/vol trypsin (Thermo Fisher
Scientific) in Versene.
Frozen hiPSC-CM stocks were thawed and seeded at a density
of 2 × 105 cells/cm2 onto rhLamin521 precoated dishes (2 µg/ml)
in RPMI-B27, which was supplemented with 10 µM Y-27632 and
5% FBS (Thermo Fisher Scientific) for the first 16 h. hiPSC-CMs
were then cultured in RPMI-B27 with media changes every
other day. After 1 wk (day 21 of differentiation), hiPSC-CMs
were dissociated to single cells using 0.05% trypsin-EDTA
(Thermo Fisher Scientific) and seeded at the desired density
for the downstream assays.
Gene editing
hiPSCs with a heterozygous c.672C>T mutation in the LMNA
gene (resulting in p.Arg225*, or R225X) were generated through
lentiviral reprogramming of dermal fibroblasts from a 56-yr-old
male patient with severe cardiac laminopathy (Siu et al., 2012).
Cells were obtained at passage 29, adapted to culture in E8/
rhLaminin521, and banked at passage 34. These hiPSC stocks
were confirmed to be Mycoplasma-negative (MycoAlert Detec-
tion Kit; Lonza) and proved euploid by conventional G-banding
karyotyping (Diagnostic Cytogenetics). Cell identity was tested
by Sanger sequencing of a genomic PCR product for exon 4 of
LMNA (PCR primers: 59-GGCTGGGTGATGACAGACTT-39 and 59-
TACTGCTCCACCTGGTCCTC-39; sequencing primer: 59-GCC
CTAGTGGACAGGGAGTT-39), which confirmed the expected
c.672C>T heterozygous mutation.
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The mutation was corrected into the wild-type allele by
adapting a previously described two-step method for scarless
genome editing relying on CRISPR/Cas9-facilitated homologous
recombination of a targeting vector containing the wild-type
allele in one homology arm, and an excisable piggyBac drug
resistance cassette (Fig. S1 A; Yusa et al., 2011; Yusa, 2013). Since
the c.672C>T mutation lies close to the 39 splice acceptor site of
exon 4 (Fig. S1 B), we reasoned that any intergenic mutation
could have poorly predictable effects on LMNA splicing. To avoid
any kind of genomic scar, we identified a suitable endogenous
“TTAA” site in the third intron of LMNA and located 151 bp
upstream to the c.672C>Tmutation in exon 4 (Fig. S1 B). Further,
we designed sgRNAs spanning such TTAA sites, so that only the
endogenous allele could be cut by CRISPR/Cas9. This strategy
allowed us to avoid inserting any additional mutation onto one
of the homology arms in the targeting vector (such as those
classically used to disrupt the protospacer adjacent motif [PAM]
site). Two sgRNAs were designed using the Zhang lab CRISPR
design tool (Ran et al., 2013) and had a score higher than 75%,
indicating a very high in silico predicted specificity (sgRNA1: 59-
CTACCAGCCCCACTTTAACC-39 and sgRNA2: 59-TCAGCTCCC
AGGTTAAAGTG-39, sequences without PAM site). To further
decrease the risk of CRISPR/Cas9 off-target activity, we adopted
the enhanced specificity Streptococcus pyogenes Cas9 (eSpCas9)
developed by Slaymaker et al. (2016). The sgRNA was cloned
into the eSpCas9(1.1) plasmid (71784; Addgene) using a standard
method based on restriction digestion with BbsI followed by li-
gation of a double-stranded oligo (Ran et al., 2013). The resulting
plasmids were named eSpCas9(1.1)_LMNA_sgRNA1 and eSp-
Cas9(1.1)_LMNA_sgRNA2. The sequences were confirmed by
Sanger sequencing, and the sgRNAs were validated to have a
high on-target activity as measured by T7E1 assay in HEK293
cells (which was comparable to that observed using wild-type
SpCas9).
The LMNA targeting vector was constructed starting from the
MV-PGK-Puro-TK_SGK-005 plasmid (Transposagen), which
contains a piggyBac transposon encoding for a PGK-EM7
promoter-driven dual positive/negative selection cassette (pu-
romycin N-acetlytransferase, ensuring resistance to puromycin,
and truncated Herpes simplex virus thymidine kinase, conferring
sensitivity to ganciclovir or its analogue fialuridine). First, the
piggyBac cassette was excised using NsiI and BsiWI and isolated.
Then, a backbone with ends suitable for the subsequent overlap-
based assembly was obtained from this same plasmid after re-
moval of the piggyBac cassette using NotI and AscI. Finally, these
two fragments were reassembled together with two PCR prod-
ucts representing the 59 and 39 homology arms to the LMNA
gene. The two homology arms were ∼1 kb long and were am-








CACAGCC-39 (for the 39 homology arm). For this, Q5 High-Fidelity
DNA Polymerase (New England Biolabs) was used according
to the manufacturer’s instructions. The four-way assembly
reaction was performed using the NEBuilder HiFi DNA As-
sembly Kit (New England Biolabs) according to the manu-
facturer’s instructions, and the resulting targeting plasmid
was named pbLMNA_R225R. Sanger sequencing confirmed
that the 39 homology arm contained the wild-type R225R al-
lele, while the remaining genomic sequence of both homology
arms was identical to that of the R225X hiPSC line as no
single-nucleotide polymorphisms were identified. The clon-
ing strategy was designed so that during PCR, the “TTAA” site
was inserted both at the end of the 59 homology arm and at the
start of the 39 homology arm, ensuring that the piggyBac
cassette contained within could be excised using transposase
while leaving behind a single “TTAA” matching the original
genomic sequence (Fig. S1 A).
For the first gene targeting step, 7.5 × 104 hiPSCs were seeded
in each well of a 6-well plate and immediately transfected using
GeneJuice (Millipore) according to the manufacturer’s in-
structions. Briefly, for each well, 3 µl of GeneJuice was mixed
with 100 µl of Opti-MEM (Thermo Fisher Scientific) and incu-
bated for 5 min at RT. 1 µg of DNA was added to the transfection
solution (equally divided between pbLMNA_R225R and either
eSpCas9(1.1)_LMNA_sgRNA1 or eSpCas9(1.1)_LMNA_sgRNA2),
which was further incubated for 15 min at RT and finally added
to the cell suspension. After 16 h from transfection, cells were
washed with Dulbecco’s PBS and cultured for another 3 d. Gene-
targeted cells were selected by adding 1 µg/ml puromycin to the
media for 4 d, after which the dose was reduced to 0.5 µg/ml.
10 µM Y-27362 was added for the first 48 h of selection. Puro-
mycin was then maintained at all times until the second gene
targeting step to prevent silencing of the piggyBac transgene.
After 7 d from the transfection, 10–15 individual and well-
separated colonies could be identified in each well of a 6-well
plate, indicating that they likely arose from clonal expansion of a
single gene-edited hiPSC. Colonies were manually picked fol-
lowing gentle treatment with Versene to facilitate their de-
tachment from the matrix, and individually expanded as
individual lines. Clones were screened by genomic PCR using
LongAmp Taq Polymerase (New England Biolabs) according to
the manufacturer’s instructions, except that all reactions were
performed using an annealing temperature of 63°C and an ex-
tension time of 2 min. The primer sequences are reported in
Table S7, and the genotyping strategies are illustrated in Fig. S1.
Briefly, junctional PCRs for both the 59 and 39 integration site
(59- and 39-INT) were used to confirm site-specific integration,
while locus PCRs were used to monitor the presence of residual
wild-type alleles. This allowed discrimination of homozygous
clones from heterozygous ones or mixed cell populations. Fi-
nally, PCRs of the targeting vector backbone (59- and 39-BB)
were performed to exclude random integration of the plasmid
elsewhere in the genome. Homozygous clones with only on-
target integration events were selected (3 out of 18 and 2 out
of 24 for sgRNA1 and sgRNA2, respectively). These positive
clones were further characterized by Sanger sequencing of the
59- and 39-INT PCR products to confirm the presence of the wild-
type R225R allele in homozygosity (found in all of the five lines)
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and exclude other unwanted mutations elsewhere in the locus
(absent in all five lines). Two clones (one for each sgRNA) were
karyotyped by standard G-banding, which confirmed their eu-
ploidy, and were therefore selected for the second gene-
targeting step. These clones were named pb R225R g1 and pb
R225R g2 (Fig. S1 C).
To remove the piggyBac and restore the LMNA locus to its
original form, pb R225R g1 and pb R225R g2 hiPSCs were
transfected as described above but using 1 µg of excision-only
piggyBac transposase expression vector (PBx; Transposagen).
Puromycin was removed from the media the day before trans-
fection, and subsequently omitted. After 3 d from the transfec-
tion, the populations were passaged as single cells, and 104 cells
were seeded per 10-cm plate in the presence of 10 µM Y-27362.
The next day, negative selection of cells still possessing the
piggyBac cassette was initiated by adding 200 nM fialuridine.
10 µMY-27362 was added for the subsequent 48 h. Selection was
complete after 5 d, at which point 10–50 individual and well-
separated colonies could be identified in each 10-cm dish. Indi-
vidual colonies were isolated, clonally expanded, and screened
by genomic PCR as described above to identify those with ho-
mozygous reconstitution of the wild-type allele (5 out of 30 and
6 out of 39 for sgRNA1 and sgRNA2, respectively). These were
further characterized by sequencing to ensure that the sequence
surrounding the “TTAA” site was faithfully reconstituted upon
piggyBac excision (confirmed in a subset of four lines, two for
each sgRNA; Fig. S1, C and D).
To exclude the prevalence of off-target mutations as result of
CRISPR/Cas9 gene editing, we predicted potential off-targets for
each sgRNA using Cas-OFFinder (Bae et al., 2014) and experi-
mentally examined a subset of putative high-risk sites. For this,
we determined all possible off-targets allowing for up to three
mismatches between the sgRNA and the genomic target, or up to
one mismatch while allowing a single base pair bulge in either
molecule. In both cases, we considered both canonical SpCas9
PAM sites (NGG, where N is any nucleotide), and noncanonical
SpCas9 PAM sites (NAG) that may allow cleaving albeit at lower
frequency (Hsu et al., 2013). Table S1 reports the resulting list of
potential off-targets and their annotation to nearby RefSeq
genes. Notably, no overlap was observed between the nearest
genes to possible off-targets of sgRNA1 and sgRNA2, indicating a
very low risk of inducing mutations affecting the same gene. We
experimentally validated the sequence of potential off-targets
that (1) had two or fewer mismatches (no bulge) or (2) had
three mismatches (no bulge) or one mismatch and one bulge,
and fell within an exon, the proximal promoter (<1 kb from a
transcription start site), the poly-adenylation site (<1 kb from a
transcription end site), or a splice donor/acceptor site (<100 bp
from an exon) of genes expressed during hPSC-CM differenti-
ation (fragments per kilobase of transcript per million mapped
reads is >1; Bertero et al., 2019). These criteria identified three
possible high-risk off-targets for each sgRNA, which were as-
sessed by Sanger sequencing of genomic PCR products (primers
reported in Table S8). No such off-target mutation was ob-
served, confirming the high specificity of the gene editing de-
sign. We also confirmed silencing of the reprogramming
transgenes that had been delivered by lentiviral transduction to
generate the R225X hiPSC line by RT-qPCR, as previously de-
scribed (Siu et al., 2012). No amplification was observed in any
of the hiPSC lines analyzed after 40 PCR cycles, confirming
transgene silencing and lack of reactivation following clonal
selection. Finally, two clones (one for each sgRNA), were kar-
yotyped by standard G-banding, which confirmed their eu-
ploidy, and therefore selected for subsequent functional
experiments. These clones were named R225R g1-15 and R225R
g1-38, and are referred to in the text and figures as Corr.1 and
Corr.2.
Parental R225X hiPSCs (referred to in the text and figures as
Mutant or Mut) were cultured in parallel throughout the whole
gene editing procedure to provide a passage-matched control,
and were rebanked at passage 49 together with Corr.1 and
Corr.2. These cells were subjected to the same genomic quality
controls as the corrected lines. Mutant and Corrected hiPSCs to
be used for derivation of hiPSC-CMs were cultured between
passage 50 to 60 before resorting to a new frozen stock.
MEA
MEA analyses were performed on hiPSC-CM monolayers at
day 30 of differentiation. hiPSC-CMs at day 21 of differentia-
tion were seeded at a density of 5 × 104 cells per well of 48-well
MEA plates (CytoView MEA 48; Axion Byosystems) precoated
with rhLaminin521 (2 µg/ml). Cells were cultured in RPMI-B27
with media changes every other day. After 9 d (day 30 of dif-
ferentiation), cells were prepared for MEA analysis by chang-
ing the culture media to Tyrode’s buffer (140 mMNaCl, 5.4 mM
KCl, 1.8 mM CaCl2, 1 mM MgCl2, 0.33 mM NaH2PO4, 5 mM
D-glucose, and 10 mM Hepes; pH adjusted to 7.36) prewarmed
at 37°C. After 10 min of equilibration in Tyrode’s buffer at 37°C,
MEA data were acquired for 5 min using the Maestro MEA
system (Axion Biosystems) using standard recording settings
for spontaneous cardiac field potentials. Data acquisition and
automated data analysis were performed using Axis software
version 2.1. Standard acquisition settings have 130 × gain, and
record from 1 to 25,000 Hz, with a low-pass digital filter of
2 kHz for noise reduction. Automated data analysis was fo-
cused on the 30 most stable beats within the recording period.
The beat detection threshold was 100 µV, and the FPD detec-
tion used an inflection search algorithm with the threshold set
at 1.5 × noise to detect the T wave. The FPD was corrected for
the beat period according to the Fridericia’s formula: FPDc =
FPD/(beat period)1/3 (Asakura et al., 2015; Rast et al., 2016).
Reported results for individual wells were calculated by aver-
aging all of the electrodes. In certain instances, poor signal
quality and/or irregularity of field potential behavior pre-
vented the calculation of certain parameters (such as FPD). The
presented data constitute all recorded values that could be
reliably measured by the software based on automatic quality-
control thresholds.
For pharmacological studies of P/Q- and L-type calcium cur-
rent inhibition, Tyrode’s buffer was supplemented with 2 µM
ω-conotoxin MVIIC, 0.5 µM ω-agatoxin TK, or 0.001–0.5 µM
verapamil (all from Tocris). hiPSC-CMs were incubated at
37°C for 20 min or 10 min (for ω-conotoxin and ω-agatoxin, or
verapamil, respectively) before MEA data acquisition.
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Whole-cell patch clamp
Whole-cell patch clamp recordings were obtained from indi-
vidual hiPSC-CMs at day 30 of differentiation. To promote a
mature phenotype and enhance cell viability during the invasive
patch procedure, we cultured hiPSC-CMs onto biomimetic ani-
sotropic nanopatterns (Macadangdang et al., 2015; Carson et al.,
2016). hiPSC-CMs at day 21 of differentiation were seeded at a
density of 4.5 × 105 cells per well of 35-mm glass-bottom Fluo-
roDish with nanopatterned surfaces precoated with rhLami-
nin521 (2 µg/ml). Anisotropically nanofabricated substrata
with 800-nm topographic features were fabricated via UV-
assisted capillary force lithography as previously described
(Macadangdang et al., 2015). First, liquid polyurethane acrylate
(PUA) prepolymer was drop-dispensed onto a silicon master
mold. A transparent polyester film was then placed on top of the
dispensed PUA. After exposure to UV radiation (λ = 250–400
nm), the film was peeled away from the silicon master, creating
a PUA mold. A polyurethane-based prepolymer (NOA76; Nor-
land Products) was then drop-dispensed onto standard glass
coverslips, and the PUA mold was placed on top. The mold was
then exposed to UV radiation for curing. After curing, the PUA
mold was peeled off, leaving behind anisotropically nano-
fabricated substrata for cell culture. Dishes were sterilized and
activated by gas plasma treatment before coating with rhLami-
nin521. After 9 d, cells were assayed by whole-cell patch clamp
on the 37°C heated stage of an inverted DIC microscope (Nikon)
connected to an EPC10 patch clamp amplifier and computer
running Patchmaster software version 2 × 73.2 (HEKA). Cells on
patterned coverslips were loaded onto the stage and bathed in
Tyrode’s buffer. An intracellular recording solution (120 mM
L-aspartic acid, 20 mM KCl, 5 mM NaCl, 1 mM MgCl2, 3 mM
Mg2+-ATP, 5 mM EGTA, and 10 mM Hepes) was used in con-
junction with borosilicate glass patch pipettes (World Precision
Instruments) with a resistance in the range of 2–6 MΩ. Offset
potentials were nulled before formation of a gigaΩ seal, and fast
and slow capacitance was compensated for in all recordings.
Membrane potentials were corrected by subtraction of a 15-mV
liquid junction potential calculated by the HEKA software.
Current injection was controlled by the software and used to
hold patched cells at an artificial resting membrane potential of
−70 mV. Cells that required >100 pA of current to achieve a −70-
mV resting membrane potential were excluded from analysis as
excessive application of current was taken as indication of poor
patch quality and/or membrane integrity. To generate a single
action potential, a 5-ms depolarizing current pulse of 50 nA was
then applied and the resulting voltage change recorded in cur-
rent clamp mode. Action potential rise times were calculated as
the time taken to reach 90% maximum action potential ampli-
tude from 10% of themaximum amplitude. The exponential time
constant (τ) was calculated from 90% to 10% repolarization of
the action potential. Action potential duration was calculated as
the time delay between 10% of the maximum depolarization and
90% repolarization from the maximum action potential ampli-
tude. Gap-free recordings of spontaneous cardiomyocyte activ-
ity were then collected for 30 s with 0 pA current injection to
provide a measure of the maximum diastolic membrane po-
tential held by the cell without current input.
Assessment of intracellular calcium fluxes
Calcium fluxes were assessed in hiPSC-CMmonolayers at day 30
of differentiation. hiPSC-CMs at day 21 of differentiation were
seeded at a density of 5 × 105 cells per well of a six-well plate
precoated with rhLaminin521 (2 µg/ml). After 9 d, cells were
prepared for imaging by incubation for 30min at 37°C with 1 µM
Fluro-4, AM (Thermo Fisher Scientific) diluted in culture media.
Cells were rinsed in fresh media for 30 min at 37°C, and equil-
ibrated in Tyrode’s buffer prewarmed at 37°C for 10 min. hiPSC-
CMs were paced at 1 Hz using a C-Dish for a six-well plate
connected to a C-Pace EM cell stimulator (both from IonOptix)
providing biphasic field stimulation (pulses of 10 V/cm for 20
ms). Videos of Fluo-4 fluorescence (excitation/emission of 494
and 516) were recorded at 20 frames per second (fps) for at least
five contractions using a Nikon Ti-E epi-fluorescent microscope
with a 20× objective and 1× coupler between the microscope and
Hamamatsu flash V3 camera. Videos were obtained for at least
20 random fields of view (FOVs). A customMatlab program was
used to define the region of interest (ROI; containing an indi-
vidual hiPSC-CM), threshold the Fluo-4 intensity based on the
surrounding nonfluorescent background, and track the average
ROIFluo-4 fluorescence (F) over time. The relaxation time con-
stant τ was determined by fitting the formula F(t) = Ae−t/τ + B to
the decay phase of the Fluo-4 transient profile, where t is time in
seconds and A and B are fitted constants.
Contraction correlation quantification (CCQ) analysis of
cardiac contractility in hiPSC-CM monolayers
CCQ analysis was performed on hiPSC-CMmonolayers at day 30
of differentiation. hiPSC-CMs at day 21 of differentiation were
seeded at a density of 106 cells per well of a six-well plate pre-
coated with rhLaminin521 (2 µg/ml). After 9 d, cells were paced
at 1 Hz as just described for the measurement of calcium fluxes.
Bright-field videos of at least 10 contractions in multiple random
FOVs were recorded at 30 fps using a Nikon TS100 microscope
with a 20× objective and 1× coupler between the microscope
and a Canon VIXIA HF S20 camera. Videos were analyzed by
CCQ using a custom Matlab script, as previously described
(Macadangdang et al., 2015). Briefly, this method utilizes parti-
cle image velocimetry and digital image correlation algorithms
to provide relevant contractile endpoints from bright field video
recordings. A reference video frame is divided into a grid of
windows of a set size. Each window is run through a correlation
schemewith a second frame, providing the new location for that
window in the second frame. This displacement is converted
into a vector map, which provides contraction angles and, when
spatially averaged, contraction magnitudes. The correlation
equation used provides a Gaussian correlation peak with a
probabilistic nature that provides sub-pixel accuracy.
Generation and biomechanical characterization of 3D-EHTs
3D-EHTs were generated and characterized with minor changes
to a previously described method (Leonard et al., 2018). Racks of
polydimethylsiloxane (PDMS) posts were fabricated by pouring
uncured PDMS (Sylgard 184 mixed at a 1:10 curing agent to base
ratio) into a custom acrylic mold. Glass capillary tubes (1.1 mm in
diameter; Drummond) were cut to length and inserted into the
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holes on one side of the mold before curing to render one post in
each pair rigid. Post racks were baked overnight at 65°C before
being peeled from themolds. Racks consisted of six pairs of posts
that were evenly spaced to fit along one row of a standard 24-
well plate. Fabricated posts were 12.5 mm long and 1.5 mm in
diameter with a cap structure (2.0 mm in diameter for the
topmost 0.5 mm) to aid in the attachment of 3D-EHTs. The
center-to-center post spacing (corresponding to precompacted
3D-EHT length) was 8 mm. Prior to casting 3D-EHTs, all 3D-
printed parts and PDMS posts were sterilized in a UVO
Cleaner (342; Jetlight) for 7 min, submerged in 70% ethanol, and
rinsed with sterile deionized water. Rectangular 2% wt/vol ag-
arose/PBS casting troughs (12 mm in length, 4 mm in width, and
∼4 mm in depth) were generated in the bottom of 24-well plates
by using custom 3D-printed spacers (12 mm × 4 mm in cross-
section and 13 mm long) as negative molds. PDMS post racks
were positioned upside down with one rigid-flexible post pair
centered in each trough (leaving a 0.5-mm gap between the tip
of the post and the bottom of the casting trough). Each tissue
consisted of a 97-µl fibrinogen-media solution (89 µl of RPMI-B-
27; 5.5 µl of 2× DMEM with 20% FBS; and 2.5 µl of 200 mg/ml
bovine fibrinogen; Sigma-Aldrich) containing 5 × 105 hiPSC-CMs
and 5 × 104 supporting HS27a human bone marrow stromal cells
(ATCC), which was chilled and mixed with 3 µl of cold thrombin
(at 100 U/ml; Sigma-Aldrich) just before pipetting into the ag-
arose casting troughs. The 3D-EHT mixtures were incubated for
90 min at 37°C, at which point the fibrin gels were sufficiently
polymerized around the posts to be lubricated in media and
transferred from the casting troughs into a 24-well plate with
fresh 3D-EHT media (RPMI-B-27 with penicillin/streptomycin,
and 5 mg/ml aminocaproic acid; Sigma-Aldrich). 3D-EHTs were
supplied with 2.5 ml/well of fresh 3D-EHT media three times
per week.
In situ force measurements were performed after 4 wk from
3D-EHT casting. To pace 3D-EHTs, post racks were transferred
to a custom-built 24-well plate with carbon electrodes connected
through an electrical stimulator (S88X; Astro Med Grass Stim-
ulator) to provide biphasic field stimulation (5 V/cm for 20-ms
durations) during imaging (Leonard et al., 2018). 3D-EHTs were
equilibrated in Tyrode’s buffer (containing 1.8 mM Ca2+) pre-
heated to 37°C and paced at 1 Hz, which was greater than the
average spontaneous twitch frequency of the tissues. Videos of
at least 10 contractions were recorded inside a 37°C heated
chamber using a monochrome CMOS camera (SMN-B050-U;
Mightex) with a board lens (TBL 8.4–2 5MP; The Imaging
Source). The camera lens configuration allowed for a capture
rate of 65 fps with 8.3 µm/pixel resolution and a FOV of 1,536 ×
400 pixels, which was sufficient to capture images of the whole
3D-EHT from rigid to flexible post. A custom Matlab program
was used to threshold the images and track the centroid of the
flexible post relative to the centroid of the rigid post. The twitch
force profile, Ftwitch(t) = kpost × Δpost(t), was calculated from the
bending stiffness kpost and deflection of the flexible post Δpost at
all time points (t), where kpost = 0.95 μN/µm was determined
from beam bending theory using the dimensions of the posts and
taking the Young’s modulus of PDMS to be 2.5 MPa (Sniadecki
and Chen, 2007). The twitch force and twitch kinetics were
calculated from the twitch force profiles using a custom Matlab
program.
RT-qPCR
RT-qPCR was performed as previously described for 2D cell
monolayers (Bertero et al., 2019) or 3D-EHTs (Leonard et al.,
2018). 2D monolayers were lysed in RLT buffer supplemented
with 1% 2-mercaptoethanol before RNA purification using the
RNeasy Mini Kit (QIAGEN) according to the manufacturer’s
instructions and including the on-column DNase digestion step.
cDNAwas synthetized by reverse transcription of 500 ng of total
RNA using M-MLV RT (Invitrogen) and random hexamer
priming according to the manufacturer’s protocol and including
RNase OUT (Invitrogen). RT-qPCR was performed in technical
duplicate with SYBR Select Master Mix (Applied Biosystems)
using 10 ng of cDNA and 400 nM forward and reverse primers.
Reactions were run for 40 cycles on a 7900HT Fast Real-Time
PCR System (4329001; Applied Biosystems), all according to the
manufacturers’ instructions. Gene expression relative to the
housekeeping gene RPLP0 was calculated using the ΔCt method
as 2(Ct gene − Ct housekeeping). Where indicated, gene expressionwas
further normalized to a control condition (which was set at the
arbitrary value of 1). Primers were designed using PrimerBlast
and confirmed to amplify a single product. A complete list can be
found in Table S9.
For 3D-EHTs, RNA was extracted using RNeasy Plus Micro
Kit (QIAGEN) according to the manufacturer’s instructions ex-
cept for the following modifications. Individual 3D-EHTs were
predigested using 2 mg/ml Proteinase K in 100 µl Dulbecco’s
PBS for 10 min at 56°C in agitation. Cells were then lysed by
adding 350 µl of RLT Plus Buffer supplemented with 1% 2-
mercaptoethanol, and cleared through the gDNA Eliminator
Mini Spin Column. The RNA lysate was finally prepared for
binding to the RNeasy MinElute Spin Column by adding 250 µl
of 200-proof ethanol. All subsequent steps were performed ac-
cording to the supplier’s recommendations. 10 µl of eluted RNA
(corresponding to 50–100 ng) was subjected to reverse tran-
scription, and 2 ng of cDNAwas used as a template for RT-qPCR,
all as described for 2D monolayers.
Flow cytometry
Flow cytometry was performed at different differentiation time
points from day 0 through day 30 on either live cells for surface
markers (day 6 and day 10 of differentiation) or PFA-fixed cells
for intracellular markers (day 0, day 2, day 14, and day 30 of
differentiation). Single-cell suspensions were obtained by in-
cubation in TrypLE (Thermo Fisher Scientific) for 5–10 min at
37°C. Following one wash in RPMI supplemented with 10% FBS
and 2.5 U/ml DNase (this and all subsequent centrifugation steps
performed at 300 g for 4 min at RT), cells were incubated for
5 min at RT with LIVE/DEAD Fixable Violet Dead Cell Stain Kit
(L34955; Thermo Fisher Scientific) diluted 1:2,500 in PBS. Cells
were washed once with PBS 1% BSA (FACS buffer) and either
used directly for staining or fixed with 4% PFA in PBS for 10 min
followed by two washes in FACS buffer. Primary antibody in-
cubation was performed for 30 min at RT using ∼1 M cells per
condition in 100 µl. Antibodies were diluted either in FACS
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buffer (for live cells) or in PBS supplementedwith 5% FBS, 0.75%
saponin, and 0.01% Triton X-100 (permeabilization and blocking
buffer, for fixed cells). Surface marker antibodies were pre-
conjugated with fluorophores: mouse monoclonal anti-PDGFRA-
APC (clone PRa292; FAB1264A; R&D Systems), 1:10 dilution;
mouse monoclonal anti-CD82-PE (clone ASL-24; 342104; Biol-
egend), 1:20 dilution; mouse monoclonal anti-CD56-PE (clone
B159; 555516; BD Biosciences), 1:5 dilution; mouse monoclonal
IgG1-APC (clone 11711; IC0002A; R&D Systems), 1:10 dilution; and
mouse monoclonal IgG1-PE (clone MOPC-21; 55749; BD Bio-
sciences), 1:5 dilution. After staining with these antibodies, cells
were washed twice in FACS buffer and directly analyzed.
Intracellular marker antibodies were not conjugated: rabbit
polyclonal anti-OCT4 (ab19857; Abcam), 1:200 dilution; goat
polyclonal anti-TBXT (AF2085; R&D Systems), 1:40 dilution;
mouse monoclonal anti-TNNT2 (clone 13–11; MA5-12960; In-
vitrogen), 1:200 dilution; rabbit monoclonal anti–NKX2-5 (clone
E1Y8H; 8792S; Cell Signaling), 1:200 dilution; rabbit polyclonal
anti-TTN (TTN-1; Myomedix), 1:300 dilution; mousemonoclonal
anti-ACTC1 (clone EA-53; ab9465; Abcam), 1:300 dilution; rabbit
polyclonal anti-TNNI3 (clone EP1106Y; ab52862; Abcam), 1:100
dilution; rabbit normal IgG (27295; Cell Signaling), 1:200 dilu-
tion; goat normal IgG (AB-108-C; R&D Systems), 1:200 dilution;
and mouse normal IgG (14–4714-85; eBioscience), 1:200 dilution.
After staining with these antibodies, cells were washed twice
with PBS supplemented with 5% FBS and 0.75% saponin (wash
buffer) and incubated for 30 min at RT (protected from light)
with donkey secondary antibodies against the appropriate spe-
cies and conjugated to Alexa Fluor 488 or 647 (Invitrogen), all
diluted 1:250 in wash buffer. Cells were further washed once
with wash buffer and once with FACS buffer before analysis.
Samples were run on a BD FACSCanto II equipped with 405-,
488-, and 647-nm lasers, and data from at least 20,000 valid
events were acquired with the BD FACSDIVA software. Analysis
was performed with FloJo version 10 software. After identifying
single cells based on forward and side scatter properties, sam-
ples were gated to be negative for the LIVE/DEAD staining (live
cells). Positivity for lineage markers was defined by additional
gates based on the signal from isotype antibody negative control
stainings, as depicted in the figures.
Immunofluorescence
Immunofluorescence was performed on hiPSC-CMs after re-
plating onto glass-bottom 24-well culture dishes (P24-1.5H-N;
CellVis). Dishes were prepared by (1) incubation with 0.5 M
acetic acid for 30 min at RT; (2) three washes with deionized
water; (3) incubation with 0.1% polyethylenimine overnight at
4°C; (4) two washes with PBS and one wash with deionized
water; and finally (5) coating with 2 µg/ml rhLaminin521 (diluted
in PBS with Ca2+ and Mg2+) overnight at 4°C (all solutions filter-
sterilized before use). hiPSC-CMs were seeded at a density of 5 ×
104 cells per well, and cultured for 1 wk before fixation with 4%
PFA in PBS for 10 min at RT followed by three washes with PBS.
Cells were permeabilized and blocked in PBS with 0.1% Triton X-
100 and 5% normal donkey serum for 30 min, and subsequently
incubated overnight at 4°C with primary antibodies diluted in
antibody buffer (PBS with 0.1% Triton X-100 and 1% normal
donkey serum). The following antibodies were used: goat poly-
clonal anti-lamin A/C (sc-6215; Santa Cruz), 1:50 dilution; rabbit
polyclonal anti–lamin B1 (PA5-19468; Invitrogen), dilution 1:300;
rabbit polyclonal anti-TTN (TTN-1; Myomedix), 1:300 dilution;
mouse monoclonal anti-ACTC1 (clone EA-53; ab9465; Abcam),
1:300 dilution; and rabbit polyclonal anti-TNNI3 (clone EP1106Y;
ab52862; Abcam), 1:200 dilution. After three washes with PBS for
5 min, secondary antibodies (donkey anti-rabbit Alexa Fluor 488,
donkey anti-goat Alexa Fluor 568, and donkey anti-mouse Alexa
Fluor 647, all used at 1 µg/ml) were diluted in antibody buffer and
incubated for 1 h at RT in the dark. Nuclei were counterstained
with DAPI (5 µg/ml in PBS) for 3 min at RT, and finally washed
three times in PBS. Stainings were imaged in PBS at 37°C using a
Nikon Eclipse Ti epi-fluorescent microscope using a Nikon CFI
PlanApo VC 60×Water Immersion lens (NA 1.2). Sample emission
was captured sequentially through NIKON filter sets (UV-2E/C
DAPI/Hosechst; FITC HYQ; TRITC HYQ; and CY5 HYQ) by a
Hamamatsu ORCA-Flash4.0 V3 Digital CMOS camera and the
NIS-Elements AR software (version 5.11), which was also used to
create composite images.
Immunofluorescence combined with 3D-DNA FISH
(ImmunoFISH)
ImmunoFISH was performed as previously described (Bertero
et al., 2019), with minor modifications (procedure performed at
RT unless mentioned otherwise). DNA FISH probes were gen-
erated using bacterial artificial chromosomes (BACs) from the
BACPAC Resources Center: CH17-4L20 (CACNA1A), CH17-291L21
(LRRC4B), CH17-197I17 (PCDHGB4), CH17-122P20 (LGASLS14), and
CH17-54F13 (VAV1). Following purification using the QIAGEN
Plasmid Midi Kit, each BAC was validated by PCR using two
primer sets specific for the expected genomic region. BACs were
labeled with SpectrumGreen (Vysis) for 4 h at 15°C using the
Vysis Spectrum Nick Translation Kit according to the manu-
facturer’s recommendations. Probes were purified with the
QIAGEN PCR purification kit and then precipitated together
with 40 µl Salmon Sperm DNA (Thermo Fisher Scientific) and
60 µl Human Cot-1 DNA (Thermo Fisher Scientific) by adding
15 µl sodium acetate (3 M; pH 5.5) and 390 µl 100% ethanol.
After incubation for 2 h at −20°C, probes were spun at 16,000 g
for 30 min at 4°C and resuspended in 50 µl hybridization buffer
(50% formamide, 2× SSC, and 10% dextran sulfate).
Poly-L-lysine slides (Sigma-Aldrich) were precoated with 0.5
or 2 µg/ml rhLaminin521 (for hiPSCs and hiPSC-CMs, respec-
tively), and 4 × 104 cells were seeded on an ∼2-cm2 spot outlined
by a hydrophobic layer for 4 h at 37°C. After fixation with 4%
PFA in PBS and quenching in 0.1 M Tris-HCl, pH 7.4 (10 min
each), cells were washed twice in PBS, equilibrated in 20%
glycerol/PBS for 20 min, and stored overnight in 50% glycerol/
PBS at −20°C. Slides were washed twice in PBS for 5 min and
processed according to the immunofluorescence protocol just
described, except that nuclei were not counterstained with
DAPI. The following primary antibodies were used: rabbit pol-
yclonal anti–lamin B1 (PA5-19468; Invitrogen), dilution 1:300;
and mouse monoclonal anti-ACTC1 (clone EA-53; ab9465; Ab-
cam), dilution 1:300. After immunofluorescence, slides were
refixed with 3% PFA in PBS for 10 min, washed two times in
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2× SSC, denatured in 50% formamide 2× SSC, pH 7.2, for 30 min
at 80°C, and washed three times with ice-cold 2× SSC. DNA FISH
probes were also denatured for 10 min at 80°C, followed by snap
cooling on ice. Coverslips containing 10 µl of DNA FISH probes
were placed onto the slides (one probe per slide), after which
slides were sealed with rubber cement, air-dried in the dark for
30 min, and hybridized overnight at 42°C. The rubber cement
was gently peeled off to allow removal of the coverslip. Slides
were then washed thrice in 50% formamide and 50% 2× SSC, pH
7.2, at 42°C. Slides were incubatedwith DAPI (5 µg/ml in 2× SSC)
for 2 min to counterstain nuclei, and finally washed twice with
PBS. Coverslips were mounted using 10 µl of Slow Fade Gold
(Thermo Fisher Scientific) and sealed with nail polish.
Slides were imaged at 37°C using a Yokogawa CSU-W1
spinning disk confocal mounted on an inverted Nikon Eclipse Ti
base and a Nikon CFI PlanApo VC 60× Water Immersion lens
(NA 1.2). Samples were excited via full field exposure from 100
mW 405-, 490-, and 561-nm lasers. Sample emission was cap-
tured sequentially through Chroma Technology filter sets
(ET455/50, ET525/35, and ET605/52) by an Andor iXon
EM+EMCCD camera and the NIS-Elements AR software (version
5.11). Z-stacks were acquired at a step size of 0.3 µm to cover a
z-distance of 15 µm (51 stacks). 10–15 randomly selected FOVs
were imaged at a separation of three FOVs from each other.
Imaris software was used for automated image analysis (version
9.2.0; Bitplane). After removal of background signal using a
Gaussian filter (9 µm for lamin B1 and 1 µm for FISH signals,
based on the average size of each feature), nuclear lamina
boundaries were defined with the surface feature (surface detail
of 1 µm; all other parameters as default). For hiPSC-CM analysis,
nuclear lamina features for the few contaminating non-
cardiomyocytes (indicated by lack of costaining for cardiac
α-actinin) were removed at this stage. FISH signal was masked
based on the nuclear lamina boundaries to retain only the nu-
clear signal, and then loci were identified using the spot calling
feature (1 µm wide, based on the average size of FISH signal; all
other parameters as default). The distance transformation
function was then used to calculate inside distances from the
nuclear lamina and distances from the FISH spots. Statistics
were exported from Imaris and processed using a custom Py-
thon script to extract and analyze information only for diploid
nuclei (containing exactly two green FISH spots). At least 150
cells per condition were analyzed (corresponding to at least 10
FOVs), and the exact number is indicated in each figure. Dis-
tances between loci and the nuclear lamina were calculated
relative to the center of 1-µm-wide FISH spots. The resulting
data proved to follow a Gaussian distribution (based on
Kolmogorov–Smirnov normality tests) with unequal SD among
groups (based on the Bartlett’s test). Therefore, statistical
analysis was performed using the Brown–Forsythe and Welch
ANOVA test, followed by the Holm–Sidak correction of multiple
paired comparisons across preselected groups of interest (mu-
tant versus corrected, and hiPSC-CMs versus hiPSCs).
Western blot
Protein lysates were obtained using ice-cold 1× RIPA buffer
containing protease and phosphatase inhibitors (9806; Cell
Signaling) and freshly supplemented with 1 mM PMSF. After
incubation for 30 min on ice, the lysate was clarified from in-
soluble material by centrifugation at 16,000 g for 10 min at 4°C.
The protein concentration was assessed using the Pierce BCA
Protein Assay Kit (Thermo Fisher Scientific) according to the
manufacturer’s instructions. After addition of Laemmli Sam-
ple Buffer (Bio-Rad) to a final concentration of 1×, and 2-
mercaptoethanol to a final concentration of 2.5%, the samples
were denatured by heating at 95°C for 5 min. For electrophoretic
separation, 20 µg of protein for each sample was loaded onto
7.5% Mini-PROTEAN TGX Precast Protein Gels (Bio-Rad) and
run at 100 V for 60 min using 1× Tris/glycine/SDS running
buffer (Bio-Rad). Proteins were transferred onto Immobilion-P
polyvinylidene fluoride membranes (Millipore Sigma-Aldrich)
by means of tank blotting in 1× Tris/glycine (Bio-Rad) supple-
mented with 20%methanol; transfer was performed at 100 V for
60 min at 4°C. Membranes were blocked in PBS supplemented
with 0.1% Tween-20 (PBST) and 4% Blotting-Grade Blocker (Bio-
Rad) for 1 h at RT. Primary antibody incubation of whole
membranes was performed overnight at 4°C under agitation,
and antibodies were diluted in the same blocking buffer. The
following antibodies were used: goat polyclonal anti-lamin A/C
(sc-6215; Santa Cruz), 1:500 dilution; rabbit polyclonal anti–
lamin B1 (PA5-19468; Invitrogen), dilution 1:500; mouse mono-
clonal anti–lamin B2 (clone E-3; 33–2100; Invitrogen), dilution
1:200; mousemonoclonal anti-TNNI (clone OTI8H8; NBP2-46170;
Novus Biologicals), dilution 1:500; goat polyclonal anti-NKX2-5
(AF2444; R&D Systems), dilution 1:500; goat polyclonal anti-
TBXT (AF2085; R&D Systems), dilution 1:500; rabbit polyclonal
anti-POU5F1 (19857; Abcam), dilution 1:1,000; and mouse mon-
oclonal anti-GAPDH (clone 6C5; ab8245; Abcam), dilution 1:
2,000. Membranes were washed three times in PBST for 10 min
at RT, incubated for 1 h at RT with species-appropriate HRP-
conjugated secondary antibodies (Thermo Fisher Scientific) di-
luted 1:10,000 in blocking buffer, and washed three times in
PBST for 10 min at RT. Chemiluminescent reaction was initiated
by incubation with SuperSignal West Pico PLUS Chemilumines-
cent Substrate (Thermo Fisher Scientific), and images were ac-
quired using a ChemiDoc Imaging System (Bio-Rad) in “high
resolution” mode. Before reprobing with a new antibody, mem-
branes were treated with Restore Plus Western blot stripping
buffer (Thermo Fisher Scientific), washed three times, and re-
blocked. Densitometric quantification of Western blots was per-
formed using ImageJ, and protein abundance estimation was
normalized on the levels of GAPDH within each lysate.
RNA-seq
RNA-seq was performed on 2–3 × 106 hiPSC-CMs at day 14 of
differentiation on three biological replicates (independent dif-
ferentiations) per cell line. RNA-seq libraries were prepared
from 100 ng of total RNA (obtained as described above for RT-
qPCR) using the TruSeq Stranded Total RNA LT Kit with Ribo-
Zero H/M/R (all Illumina), according to the manufacturer’s
instructions. RNA-seq libraries were paired-end sequenced
on an Illumina NextSeq 500 in a high output run with 150 cycles
(75 for each end), achieving ∼40 million paired-end reads per
sample. Reads were mapped to hg38 using STAR (Dobin et al.,
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2013) and then quantified and processed through the Cufflinks
suite (Trapnell et al., 2012), all using default parameters. Dif-
ferential expressed genes exhibited a q-value <0.05 for a pair-
wise comparison and were expressed at least 1 read kilobase per
million mapped reads in one time point. Hierarchical clustering
was performed with the CummeRbund suite in R. Ontology
enrichment analysis was done using EnrichR (Chen et al., 2013).
For comparision with previously described RNA-seq data of
hESC-CM differentiation (Bertero et al., 2019), all datasets were
collectively renormalized and quantified using Cufflinks. Prin-
cipal component analysis was performed using the R function
“prcomp.”
In situ DNase Hi-C
Hi-C based on in situ proximity ligation of DNase I–digested
nuclei (DNase Hi-C) was performed with minor modifications of
a previously described method (Ramani et al., 2016; Bertero
et al., 2019). The assay was performed on ∼2 × 106 hiPSC-CMs
at day 14 of differentiation on two biological replicates (inde-
pendent differentiations) per cell line. Unless otherwise indi-
cated, all molecular biology reagents were obtained from
Thermo Fisher Scientific and reactions were performed at RT.
Cells were fixed in the dish with fresh RPMI-1640 supplemented
with 2% formaldehyde while in gentle orbital rotation for
10 min, and subsequently quenched with 25 mM glycine for
5 min at RT followed by 15 min at 4°C. Cells were then treated
with 0.05% trypsin for 10 min at 37°C, rinsed in RPMI-1640 with
10% FBS, and scraped off the plate. Cells were washed once with
PBS, flash-frozen in liquid nitrogen, and stored at −80°C. After
rapid thawing, samples were resuspended in 500 µl of ice-cold
cell lysis buffer (10 mMTris-HCl, pH 8.0, 10 mMNaCl, and 0.5%
Igepal CA-630, supplemented with the protease inhibitor cock-
tail from Sigma-Aldrich), incubated for 20 min on ice, and
dounce-homogenized 60–80 times with a tight pestle. Extracted
nuclei were centrifuged at 2,500 g for 1 min at RT (standard
spinning protocol), resuspended in 300 µl 0.5× DNase I diges-
tion buffer with 0.2% SDS and 20 mM MnCl2, and incubated at
37°C for 60 min with periodic gentle vortexing. Then, 300 µl
0.5× DNase I digestion buffer with 2% Triton X-100, 20 mM
MnCl2, and 0.4 µg/µl RNase A was added and incubated for
another 10 min. Chromatin was finally digested with 7 U of
DNase I during a 7-min incubation at RT. The reaction was
stopped with 30 µl of 0.5 M EDTA and 15 µl 10% SDS. The ef-
ficiency of DNase I digestion was confirmed by comparing the
DNA shearing patterns of small samples of undigested and di-
gested nuclei using a 6% PAGE gel (following proteinase K di-
gestion). Nuclei were spun down and resuspended in 150 µl
RNase and DNase-free water. 300 µl of AMPure XP beads
(Beckman) was added to irreversibly bind nuclei; going forward,
nuclei were therefore cleaned up by magnetic purification. In
situ reactions were performed first for end repair (15 U of T4
DNA Polymerase and 30 U of Klenow Fragment for 1 h at RT) and
dA-tailing (75 U of Klenow exo-minus for 1 h at 37°C), each in
200 µl, and followed by inactivation with 5 µl of 10% SDS and
cleanup. Nuclei were then subjected to overnight ligation of
custom T- and blunt-bridge biotin-tagged adapters (each at
8 µM; sequences detailed in Ramani et al., 2016) using 25 U of T4
DNA ligase and 5% polyethylene glycol in a 100-µl reaction in-
cubated at 16°C. The reaction was stopped with 5 µl of 10% SDS,
and nuclei were washed twice with AMPure buffer (20% poly-
ethylene glycol in 2.5 MNaCl) followed by two washes with 80%
ethanol to remove un-ligated adapter. Nuclei were then treated
for 1 h at 37°C with 100 U of T4 PNK in a 100-µl reaction to
phosphorylate the adapters. Proximity ligation of DNA ends was
performed for 4 h at RT using 30 U of T4 DNA ligase in a 1-ml
reaction maintained in gentle agitation. Nuclei were re-
suspended in 1× NEBuffer 2 (New England Biolabs) with 1% SDS,
and digested with 800 µg of Proteinase K overnight at 62°C. DNA
was precipitated by adding 60 µg glycogen, 50 µl 3 MNa-acetate
(pH 5.2), and 500 µl isopropanol followed by incubation for 2 h
at −80°C and centrifugation at 16,000 g for 30 min at 4°C. DNA
was resuspended in 100 µl water and purified with 100 µl
AMPure beads according to themanufacturer’s instructions, and
resuspended in 100 µl elution buffer (EB; 10 mM Tris-HCl, pH
8.5). Biotin pull-down was performed on the purified DNA to
isolate ligation products containing the biotin adapters. 100 µl
Myone C1 beads were mixed with the DNA for 30 min at RT
under gentle rotation. Samples were washed four times with
bind and wash buffer (5 mM Tris-HCl, pH 8.0, 0.5 mM EDTA,
1 M NaCl, and 0.05% Tween-20) and twice with EB. DNA was
then treated on the beads to perform end-repair (200-µl reac-
tion with the Fast DNA End Repair Kit for 10 min at 18°C) and
dA-Tailing (50-µl reaction with 25 U of Klenow exo-minus in
NEBuffer 2 and 1.2 mM dATP for 30 min at 37°C). Custom
Y-adapters for Illumina sequencing (each at 2 µM; sequences
detailed in Ramani et al., 2016) were then ligated using 20 U of
T4 DNA ligase for 1 h at RT in a 50-µl reaction using the Rapid
Ligation Buffer. Beads were washed four times with bind and
wash buffer and twice with EB after each of these reactions.
Finally, libraries were amplified by 12 PCR cycles with Kapa HiFi
ReadyStart Master Mix with custom barcode-containing pri-
mers (sequences detailed in Ramani et al., 2016). Libraries were
purified with 0.8× Ampure XP beads according to the manu-
facturer’s instructions, quantified with a Qubit and the DNA
high-sensitivity reagent, and pooled at equimolar ratios in
preparation for next-generation sequencing. Samples were
paired-end sequenced on three runs with an Illumina NextSeq
500 at high output with 150 cycles (75 for each end), resulting in
∼150 M paired-end reads per sample.
Hi-C data analysis
Fastq files were mapped to the hg38 genome using Burrows-
Wheeler Aligner (BWA-MEM) with default parameters, map-
ping each end of the read pairs individually. The mapped files
were processed through HiC-Pro (Servant et al., 2015), filtering
for mapping quality (MAPQ) score >30 and excluding pairs <1 kb
apart, to generate valid pairs and iterative correction of Hi-C
data (ICE)–balanced matrices at 500-kb resolution. Hi-C quality
control metrics from HiC-Pro are reported in Table S4.
Samples were clustered based on HiC-Rep scores calculated
using a resolution of 500 kb with a maximum distance of 5 Mb
and a smoothing parameter h of 1 (Yang et al., 2017). Hi-C
contact matrix heatmaps for cis or trans interactions were
generated with Cooler (https://github.com/mirnylab/cooler)
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using default parameters and logarithmic interaction probabili-
ties, without diagonals. A/B compartmentalization was com-
puted by eigenvalue decomposition of the contact maps using
HOMER (Heinz et al., 2010) with 500-kb resolution and no ad-
ditional windowing (super-resolution was also set at 500 kb).
The sign of the first eigenvector (PC1) was selected based on the
expression of ∼5,000 genes constitutively expressed across
hESC-CM differentiation (Bertero et al., 2019), so that positive
and negative values indicate A and B compartmentalization,
respectively. Saddle plots of intercompartment interaction en-
richment were generated by assigning each genomic bin to its
corresponding percentile value based on PC1 and dividing the
genome into 10 deciles. Each interaction was normalized to the
average score at the corresponding distance (for cis interactions)
or to the average of all contacts (for trans interactions) and as-
signed to a pair of deciles based on the PC1 scores of the two bins.
The data were plotted in heatmaps representing the log2 average
value for pairs of deciles, while the change between mutant and
corrected hiPSC-CMs is the log2 value of the difference in such
values. To calculate the interaction probability at varying ge-
nomic distances based on compartmentalization, each interac-
tion was assigned to A-A, B-B, or A-B based on the pairs of bins
involved, and then the average interaction score for a given
distance was normalized to the average interaction score for all
pairs of contacts at that distance. The data were plotted on a
logarithmic scale and LOESS smoothed using the R function
“geom_smooth.” Visualization of sample similarity by PC1 scores
was performed with the R function “prcomp.” Gene tracks were
generated using Integrative Genomics Viewer (Thorvaldsdóttir
et al., 2013). Changes in A/B compartmentalization were deter-
mined by a one-way ANOVA of PC1 scores across the two rep-
licates for the three cell lines, using a significance cutoff of P <
0.05 combined by the need for the average PC1 to change sign
across at least one pair of condition. Consistent changes in A/B
compartmentalization were further selected if the average PC1
score for mutant hiPSC-CMs changed sign compared with the
average PC1 score of each corrected hiPSC-CMs.
Statistical analyses
Unless specifically described elsewhere in the methods, all
statistical analyses were performed using Prism 7 (GraphPad).
The type and number of replicates, the statistics plotted, the
statistical test used, and the test results are described in the
figure legends. All statistical tests used were two-tailed. No
experimental samples were excluded from the statistical anal-
yses. Sample size was not predetermined through power cal-
culations, and no randomization or investigator blinding
approaches were implemented during the experiments and
data analyses. When a representative experiment is reported,
this exemplifies the results obtained in at least two indepen-
dent biological replications.
Data and code availability
Hi-C and RNA-seq data are available in GEO under accession no.
GSE126460. The custom code for Hi-C analyses was previously
described (Bertero et al., 2019) and is available on github
(https://github.com/pfields8/Fields_et_al_2018/).
Online supplemental material
Fig. S1 shows scarless correction of the LMNA R225X heterozy-
gous mutation in hiPSCs. Fig. S2 shows generation of lamin A/C
haploinsufficient hiPSC-CM. Fig. S3 shows characterization of
lamin A/C haploinsufficient hiPSC-CMs. Fig. S4 shows global
properties of chromatin topology in lamin A/C haploinsufficient
hiPSC-CMs. Fig. S5 shows chromatin compartment transitions
and associated gene expression changes in lamin A/C hap-
loinsufficient hiPSC-CMs. Table S1 shows CRISPR/Cas9 off-
target analysis. Table S2 shows differential gene expression
analyses of RNA-seq data. Table S3 shows gene ontology anal-
yses of RNA-seq data. Table S4 shows QC metrics of DNase Hi-C
experiments. Table S5 shows A/B compartment analyses of Hi-C
data. Table S6 shows ontology enrichment analyses of genes in
lamin A/C–sensitive B compartments. Table S7 shows genotyp-
ing strategies for the characterization of CRISPR/Cas9-edited
hiPSCs. Table S8 shows genomic PCR primers for CRISPR/
Cas9 off-target analysis. Table S9 shows RT-qPCR primers.
Video 1 shows spontaneous contractions of mutant hiPSC-CMs.
Video 2 shows spontaneous contractions of corrected hiPSC-
CMs. Video 3 shows calcium fluxes indicated by Fluo-4 fluo-
rescence in monolayers of mutant hiPSC-CMs electrically paced
at 1 Hz. Video 4 shows calcium fluxes indicated by Fluo-4 fluo-
rescence in monolayers of corrected hiPSC-CMs electrically
paced at 1 Hz. Video 5 shows CCQ analyses in monolayers of
mutant hiPSC-CMs electrically paced at 1 Hz. Video 6 shows CCQ
analyses in monolayers of corrected hiPSC-CMs electrically
paced at 1 Hz. Video 7 shows contractions of 3D-EHTs from
mutant hiPSC-CMs. Video 8 shows contractions of 3D-EHTs
from corrected hiPSC-CMs.
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Provided online are six tables. Table S1 shows CRISPR/Cas9 off-target analysis. Table S2 shows differential gene expression
analyses of RNA-seq data. Table S3 shows gene ontology analyses of RNA-seq data. Table S4 shows QC metrics of DNase Hi-C
experiments. Table S5 shows A/B compartment analyses of Hi-C data. Table S6 shows ontology enrichment analyses of genes in
lamin A/C–sensitive B compartments.
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Figure S1. Scarless correction of the LMNA R225X heterozygous mutation in hiPSCs. (A) Schematics of the gene targeting and genotyping strategies. A
targeting vector with wild-type up- and downstream homology arms (59- and 39-HA; Ex, exon) and a polycistronic piggyBac cassette carrying puromycin
N-acetyltransferase and herpes simplex truncated thymidine kinase (PuroR-ΔTK) was used in combination with eSpCas9 to drive homologous recombination
around an endogenous “TTAA” sequence proximal to the R225X mutation. Targeted clones were positively selected based on resistance to puromycin and
screened by a panel of genomic PCR assays indicated by square brackets (PCR failing for gene-targeted alleles are indicated by dashed square brackets; see
Materials and methods for details). The piggyBac cassette was subsequently excised using transposase leaving behind only a “TTAA” scar identical to the
original sequence, and clones were negatively selected based on sensitivity to fialuridine (FIAU). Corrected clones were screened by genomic PCR, Sanger
sequencing, and karyotyping. (B) Genomic sequence of the LMNA locus around the R225X mutation (highlighted by the box). The amino acid translation of
portion of LMNA exon 4 is also reported. The location and directionality of the sgRNAs used for CRISPR/Cas9 targeting are indicated by the half arrows (dashed
portion: PAM site; specificity scores are indicated). The 59- and 39-homology arms are shown with orange and yellow backgrounds, respectively. The “TTAA”
sequence key to the scarless gene targeting strategy is shown with a blue background. (C) Selected genomic PCR results from the indicated hiPSC lines at
different stages of the gene targeting procedure (see panel A). Pool, non-clonally selected hiPSCs after the first targeting step, providing a positive control for
all PCR strategies. g1/g2, sgRNA1/sgRNA2 used for the first targeting step. (D) Sanger sequencing results for genomic PCR products of LMNA intron 3-exon 4
(LOCUS PCR) from the two corrected hiPSC clones selected for further experiments. The “TTAA” sequence was faithfully reconstituted following transposase
excision of the piggyBac cassette (see Fig. 1 B for the R225R correction). (E) Sanger sequencing results for genomic PCR products of the indicated “high-risk”
putative CRISPR/Cas9 off-target (OT) sites, as predicted by in silico analysis (Table S1). The PAM sites are highlighted in yellow. No CRISPR-associated
mutation was identified. (F) RT-qPCR analysis for endogenous (endo) pluripotency genes POU5F1 (OCT4) and NANOG compared to lentiviral-encoded exog-
enous (exo) transgenes delivered during hiPSC generation from skin fibroblasts. In agreement with previous results (Siu et al., 2012), exogenous transgenes
were silenced following extensive passaging of R225X hiPSCs; lentiviral transgenes were not re-activated in corrected clonal hiPSC sublines (cycle threshold
was undetectable in all three groups under the conditions tested based on 40 PCR cycles). n = 3 cultures; average ± SEM. (G) Representative G-banding
karyotypes for the two corrected hiPSCs and passage-matched mutant hiPSCs, confirming a normal male 46 XY karyotype.
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Figure S2. Generation of lamin A/C haploinsufficient hiPSC-CMs. (A) RT-qPCR analyses for lineage-specific markers at the indicated stages of hiPSC-CM
differentiation (ME, mesoderm; CP, cardiac progenitor; CM, cardiomyocyte; see Fig. 1 C). Differences versus mutant were calculated by two-way ANOVA with
post hoc Holm–Sidak binary comparisons (*, P < 0.05; **, P < 0.05; ***, P < 0.001; n = 3 differentiations; average ± SEM). (B–E) Representative flow-cytometry
analyses at the indicated stages of hiPSC-CM differentiation. B reports expression of the pluripotency marker POU5F1 (OCT4) and of the mesoderm marker
TBXT (Brachyury): compared to hiPSCs, ME cells express Brachyury and begin to down-regulate OCT4. C and D report expression of the cardiac mesoderm
markers PDGFRA and CD56, and of the cardiomyocyte progenitor-fated marker CD82: as expected, CP are double-positive for PDGFRA and CD56, while CD82
appears in early CM at 10 d of differentiation. E reports expression of the sarcomeric proteins titin and cardiac α-actinin, confirming acquisition of CM identity
by day 14 of differentiation. (F) Representative immunofluorescence on day 14 CM for the indicated proteins (nuclei counterstained with DAPI). Scale bars,
30 μm. (G) Representative flow-cytometry analysis for the adult cardiomyocyte marker cardiac troponin I, which replaces fetal slow-skeletal troponin I during
cardiac maturation: this marker starts to be expressed in a proportion of day 30 hiPSC-CM. (H) Representative immunofluorescence on day 30 CM for the
indicated proteins (nuclei counterstained with DAPI). Scale bars, 30 μm. Throughout the figure (and in all other supplemental figures), Mut or Mutant indicates
LMNA R225X hiPSCs and Corr.1/2 or Corrected 1/2 indicate the two isogenic corrected control LMNA R225R hiPSCs.
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Figure S3. Characterization of lamin A/C haploinsufficient hiPSC-CMs. (A and B) Representative Western blots for lamin A/C and differentiation markers
during iPSC-CM differentiation (see Fig. 1 C). In A, the uncropped image shows a stronger exposure of the same lamin A/C Western blot presented in Fig. 1 F.
The expected location for putative truncated Lamin A and Lamin C due the R225X mutation is indicated by the dashed box (see Fig. 1 A), but no such truncation
product could be detected. (C) RT-qPCR during hiPSC-CM differentiation for all splicing isoforms for the LMNA gene annotated on RefSeq (A: NM_170707.4; C:
NM_005572.3; C2: NM_001282625.1; AΔ10: NM_170708.3; D: NM_001257374.3; E: NM_001282624.1; AΔ50: NM_001282626.2). Only lamin A and lamin C
could be detected at substantial levels (>0.2% of the housekeeping gene RPLP0) in any of the groups. Differences versus mutant were calculated by two-way
ANOVA with post hoc Holm–Sidak binary comparisons (*, P < 0.05; ***, P < 0.001; n = 3 differentiations; average ± SEM). (D) Representative immunoflu-
orescence A- and B-type lamins in hiPSC-CM identified by co-staining for cardiac α-actinin (ACTC1; nuclei counterstained with DAPI). Scale bars, 20 μm. (E) RT-
qPCR as described for panel C, but profiling expression of B-type lamins (**, P < 0.01; n = 3 differentiations; average ± SEM). (F) RT-qPCR in hiPSC-CMs at day
14 of differentiation to profile expression of the indicated ion-handling proteins involved in the cardiac action potential cycle (where relevant, the corre-
sponding ion current is indicated). No significant differences were detected versus mutant (two-way ANOVA with post hoc Holm–Sidak binary comparisons;
n = 3 differentiations; average ± SEM).
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Figure S4. Global properties of chromatin topology in lamin A/C haploinsufficient hiPSC-CMs. (A) Representative heatmaps of contact matrices be-
tween chromosomes. Autosomes are ranked based on their size from left to right and top to bottom. (B) Heatmaps of cis or trans interactions between active
(A) and inactive (B) chromatin compartments. 500-kb genomic bins were assigned to 10 deciles based on their PC1 score from the linear dimensionality
reduction of the Hi-C matrix (from most B to most A; Table S5), and average observed/expected distance normalized scores for each pair of deciles were
calculated. r1/r2, biological replicate 1/2 (independent differentiations).
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Figure S5. Chromatin compartment transitions and associated gene expression changes in lamin A/C haploinsufficient hiPSC-CMs. (A) On the top,
genome-wide view of 500-kb chromatin domains transitioning from B→A or A→B in corrected→mutant hiPSC-CMs (Table S5). On the bottom, genomic tracks
of chromatin compartmentalization for chromosome X. Positive and negative Hi-C matrix PC1 scores are shown in red and blue, and indicate A and B
compartments, respectively. (B) Overlap between genes up- or down-regulated in mutant hiPSC-CMs (RNA-seq on three differentiations; change greater than
twofold; q-value < 0.05) and genes located in lamin A/C–sensitive chromatin compartments (Table S5). P-values for the significance of observed overlaps were
calculated by chi-squared test (n.s., non-significant). (C) Average expression (Expr.) levels of genes found in lamin A/C–sensitive B chromatin compartments.
Data are from the RNA-seq analyses of day 14 hiPSC-CMs (Table S2), and in contrast to panel B, all genes with an average fold-change (FC) greater than two for
mutant versus corrected are reported (no filter by q-value). The genomic location of all genes is indicated, and colored backgrounds highlight genes found in
three genomic hotspots where lamin A/C haploinsufficiency leads to compartment transitions from B to A, resulting in up-regulation of multiple genes located
within (19p13.13, 19q13.33, and 5q31.3; see Fig. 6 E and Fig. 8 B). (D and E) RT-qPCR validation of gene expression changes in hiPSC-CMs matured by culture
in vitro for 30 days (D) or by generation of 3D-EHTs (E). Differences versus mutant were calculated by one-way ANOVA with post hoc Holm–Sidak binary
comparisons (*, P < 0.05; **, P < 0.01; ***, P < 0.001; n = 4 differentiations for panel D, and n = 3 3D-EHT batches for panel E; average ± SEM). (F) RT-qPCR
during hiPSC-CM differentiation for genes found in lamin A/C–sensitive B compartments. All of these factors are not normally expressed at substantial levels
(>0.2% of the housekeeping gene RPLP0) in control cells at any stage of differentiation, while they are up-regulated due to LMNA R225X mutation. With the
exception of SYT3, up-regulation in mutant cells is observed specifically and/or with the strongest magnitude in hiPSC-CM, coincidentally with the lack of the
developmental-associated transition to the B compartment of the chromatin regions containing these factors (Figs. 6 and 7). Differences versus mutant were
calculated by two-way ANOVA with post hoc Holm–Sidak binary comparisons (*, P < 0.05; **, P < 0.01; ***, P < 0.001; n = 3 differentiations; average ± SEM).
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Table S7. Genotyping strategies for the characterization of CRISPR/Cas9-edited hiPSCs
PCR Primer Sequence (59- and -39) Location Band wild
typea (bp)
Band TARGETb (bp) Band PLASMIDc
(bp)
LOCUS LMNA_FW1 CCCCTGCTCAAACATCCTCA Left to 5’ HAR 2,181 5,260 or loss-of-allele (LoA) -
LMNA_REV1 TGCAATCAGAGCTTCCCCAG Right to 3’
HAR












LMNA_REV2 CTGTGGTTGTGGGGACACTT 3’ HAR
3’-INT PB5-P2 CGTCAATTTTACGCATGATTA
TCTTTAAC
3’ ITR - 1,173 -
























aAmplicon from the wild-type allele or from the corrected allele after excision of the piggyBac cassette.
bAmplicon from the gene-targeted allele after integration of the piggyBac cassette.
cAmplicon from the targeting plasmid after its random integration.
Table S8. Genomic PCR primers for CRISPR/Cas9 off-target analysis
Putative off-target (gene) Forward primer (59- and -39) Reverse primer (59- and -39) Sequencing primer (59- and -39) Amplicon size (bp)
sgRNA1 – OT#1 (GPR27) TGTGCTTTGAGAAGCCCAGT AGGCTATGTCAGGCCAACAC TCTGGGCTCCTCTATCTTGG 1,563
sgRNA1 – OT#2 (ITGB7) TGAGCTGTACCACGTTGCTG CTTGCCAGTTACCAGGTCCC GTGTCTACAGGGTGGTTAC 1,575
sgRNA1 – OT#3 (NR6A1) ACACCCAACACAACGGGTAA GAGGATTGAGCCACGTCCTT CTACCCAGTATGCACACGAC 1,587
sgRNA2 – OT#1 (LRGUK) ACAGATGCTTTCTCCCGGTC AGCTTGGGCCTTTCACCTAC GCAGATAATCCTGATGGTAGG 1,685
sgRNA2 – OT#2 (NDUFAF4) TTTGAGTCGCAGCCTTCTGG TGCCATGCTTGTTTCAAGGC ATACCCAAGCAAATGCCTGG 1,507
sgRNA2 – OT#3 (ZZEF1) TCACCCTACGGCTGTGTTTC TGTACCAGGCCGTTTAGCTG GGTTGACAGCATTGCTCATG 1,984
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Table S9. RT-qPCR primers
Gene – isoform Forward primer (59- and -39) Reverse primer (59- and -39) Amplicon size (bp)
ATP2A2 ATGGGGCTCCAACGAGTTAC TTTCCTGCCATACACCCACAA 224
C19orf81 CCGAACGAGGAGGCCTGAC AGTATCCACCCCCTCGAGCC 147
CACNA1A AGGCATCCCTTTGATGGAGC CTGAGTTTTGACCATGCGGC 222
CACNA1C GCCGCTGCAGGAGAGTTTTA CCCACATGTGCAAGACCACA 151
CLEC11A TCCGGAATCTCCCTTCCCTT TTATTGGCACCGGACCTAGC 156
GPC4 TGGACCGACTGGTTACTGATG TGGTTTGCTGGTGTCAACCT 227
IPTR1 CGGAGCAGGGTATTGGAACA GGTCCACTGAGGGCTGAAACT 122
KCNA4 GCCAAACCCGAGTGATTCCT AAGCACTTCACCGTTCCCC 156
KCNA5 TAAGGAAGAGCAGGGCACTC TTGCTCTTGGCCTTGACGTT 174
KCND3 ACCACACTGGGATACGGAGA TTCGAACTGCCTGTTTTGGC 221
KCNH2 CAGCTCAACAGGCTGGAGAC CTTCTTGGGGAAGCTCTGGG 250
KCNJ2 GTGCGAACCAACCGCTACA CCAGCGAATGTCCACACAC 234
KCNQ1 AGCCTCACTCATTCAGACCG TCTCCAGGAGTCACCCCATT 192
LMNA – A CCATCACCACCACGGCTC GTGACCAGATTGTCCCCGAA 243
LMNA – AΔ10 AACTCCACTGGGGAAGGCT GAGTGACCGTGACACTGGAG 187
LMNA – AΔ50 ACGACGAGGATGAGGATGGA TTCTGGGGGCTCTGGGCT 175
LMNA – C CAACTCCACTGGGGAAGAAGTG CGGCGGCTACCACTCAC 123
LMNA – C2 TCGGCAGAGAAGACAAAGCC ATCAAGTCTCCCAGTCGGTG 209
LMNA – D AATCTGGTCACCCGCTCCTA CCCATCTCTTGTATGATGCTGC 86
LMNA – E AGGGCTGATTTGCCAGTGATG GCTATCAGGTCACCCTCCTTC 217
LMNB1 AGAACTGATGGAAAGCCGCA CTTCAACCTCTCTTCTTCGCCT 295
LMNB2 CGGCTCCTGCTCAAGATCTCA TTCTTGGCGCTCTTGTTGACC 194
LRRC4B GGGCATTGCTCTTCCTCTGG CGGATCACCTGGATGCCGTT 241
MESP1 TCGAAGTGGTTCCTTGGCAGAC CCTCCTGCTTGCCTCAAAGTGTC 163
MYH6 GCCCTTTGACATTCGCACTG GGTTTCAGCAATGACCTTGCC 103
NANOG (endo) TTTGTGGGCCTGAAGAAAACT AGGGCTGTCCTGAATAAGCAG 116
NANOG (exo) TCAAGCCTCAGACAGTGGTTC GGCCCGATTCCTGGCCCTCA Not determined (Siu et al., 2012)
NFIX ACAGCAGTCTCAGTCCTGGT GGGCTGGGGGATTTTTCCAT 119
NKX2-5 GAGCCGAAAAGAAAGCCTGAA CACCGACACGTCTCACTCAG 149
PCDHA10 GGAAGCTGCTGGATCGTGAA AATCAGAAGCGTTGAGCCGT 216
PCDHB15 CTGACGGGAGGCTCTGAAAG CAGACGGTCGGAAAGCTACA 132
PCDHGB4 AGCAGCACTGCACAGATACA CCCGGGTACACGTTTTCTGA 107
PDGFRA GCTCACTTCACTCTCCCCAAAG CCGGCGTTCCTGGTCTTAG 153
POU5F1 (endo) GGGTTCTATTTGGGAAGGTAT TTCATTGTTGTCAGCTTCCT 131
POU5F1 (exo) TCAAGCCTCAGACAGTGGTTC CTTCAAAGCAAGGCAAGCTT Not determined (Siu et al., 2012)
RPLP0 GGCGTCCTCGTGGAAGTGAC GCCTTGCGCATCATGGTGTT 255
RYR2 ACAACAGAAGCTATGCTTGGC GAGGAGTGTTCGATGACCACC 250
SCN5A AACGGCACCTCTGATGTGTT ACCTGAGGGTCTGCTGATAGA 199
SLC8A1 AGACCTGGCTTCCCACTTTG TGGCAAATGTGTCTGGCACT 101
SYT3 GACTACGACTGCATCGGGCA TGCTGCCTTTTGTGAAGCTG 178
TBXT CAAATCCTCATCCTCAGTTTG GTCAGAATAGGTTGGAGAATTG 143
TNNT2 TTCACCAAAGATCTGCTCCTCGCT TTATTACTGGTGTGGAGTGGGTGTGG 166
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Video 1. Spontaneous contractions of mutant hiPSC-CMs. Spontaneous contractions of mutant hiPSC-CMmonolayers at day 14
of differentiation. Phase-contrast images were acquired at 30 fps and are shown at 30 fps.
Video 2. Spontaneous contractions of corrected hiPSC-CMs. Spontaneous contractions of corrected control hiPSC-CM mono-
layers (from Corr.1 hiPSCs) at day 14 of differentiation. Phase-contrast images were acquired at 30 fps and are shown at 30 fps.
Video 3. Calcium fluxes indicated by Fluo-4 fluorescence in monolayers of mutant hiPSC-CMs electrically paced at 1 Hz.
Calcium fluxes in electrically paced (1 Hz) mutant hiPSC-CM monolayers at day 30 of differentiation. Fluo-4 epifluorescence images
were acquired at 20 fps and are shown at 20 fps.
Video 4. Calcium fluxes indicated by Fluo-4 fluorescence in monolayers of corrected hiPSC-CMs electrically paced at 1 Hz.
Calcium fluxes in electrically paced (1 Hz) corrected control hiPSC-CM monolayers (from Corr.1 hiPSCs) at day 30 of differentiation.
Fluo-4 epifluorescence images were acquired at 20 fps and are shown at 20 fps.
Video 5. CCQ analyses in monolayers of mutant hiPSC-CMs electrically paced at 1 Hz. Contractions of electrically paced (1 Hz)
mutant hiPSC-CM monolayers at day 30 of differentiation. Phase-contrast images were acquired at 30 fps and are shown at 30 fps.
Superimposed white arrows indicate the displacement vectors calculated by CCQ analysis.
Video 6. CCQ analyses in monolayers of corrected hiPSC-CMs electrically paced at 1 Hz. Contractions of electrically paced (1
Hz) corrected control hiPSC-CM monolayers (from Corr.1 hiPSCs) at day 30 of differentiation. Phase-contrast images were acquired
at 30 fps and are shown at 30 fps. Superimposed white arrows indicate the displacement vectors calculated by CCQ analysis.
Video 7. Contractions of 3D-EHTs frommutant hiPSC-CMs. Contractions of electrically paced (1 Hz) mutant 3D-EHTs analyzed 4
wk after casting. Phase-contrast images were acquired at 65 fps and are shown at 65 fps.
Video 8. Contractions of 3D-EHTs from corrected hiPSC-CMs. Contractions of electrically paced (1 Hz) corrected control 3D-
EHTs (from Corr.1 hiPSCs) analyzed 4 wk after casting. Phase-contrast images were acquired at 65 fps and are shown at 65 fps.
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